Member Publications

2010 Member Publications

Cancer Center members highlighted in bold type

Jump to first letter of first author's last name:
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Abbas R, Kombu RS, Dignam D, Gunning W, Stulberg JJ, Brunengraber H, Sanabria JR. Polyethylene glycol modified-albumin enhances the cold preservation properties of University of Wisconsin solution in rat liver and a hepatocyte cell line. J Surg Res 164:95-104, 2010.

Acheson LS, Wang C, Zyzanski SJ, Lynn A, Ruffin MT 4th, Gramling R, Rubinstein WS, Oneill SM, Nease DE Jr; for the Family HealthwareTM Impact Trial (FHITr) Group. Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the Family HealthwareTM Impact Trial. Genet Med 12:212-218, 2010.

Adelstein DJ, Moon J, Hanna E, Giri PG, Mills GM, Wolf GT, Urba SG. Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: a Southwest Oncology Group phase II trial (S0216). Head Neck 32:221-228, 2010. PMCID: PMC2967367

Adelstein DJ, Rodriguez CP. Human papillomavirus: changing paradigms in oropharyngeal cancer. Curr Oncol Rep 12:115-120, 2010.

Advani A, Coiffier B, Czuczman MS, Dreyling M, Foran J, Gine E, Gisselbrecht C, Ketterer N, Nasta S, Rohatiner A, Schmidt-Wolf IG, Schuler M, Sierra J, Smith MR, Verhoef G, Winter JN, Boni J, Vandendries E, Shapiro M, Fayad L. Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a Phase I study. J Clin Oncol 28:2085-2093, 2010.

Advani AS, Gibson SE, Douglas E, Jin T, Zhao X, Kalaycio M, Copelan E, Sobecks R, Sekeres M, Sungren S, Hsi ED. Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients. BMC Cancer 10:387, 2010. PMCID: PMC2921396

Advani AS, Gundacker HM, Sala-Torra O, Radich JP, Lai R, Slovak ML, Lancet JE, Coutre SE, Stuart RK, Mims MP, Stiff PJ, Appelbaum FR. Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia. Br J Haematol 151:430-434, 2010.

Advani AS, Lim K, Gibson S, Shadman M, Jin T, Copelan E, Kalaycio M, Sekeres MA, Sobecks R, Hsi E. OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia. Leuk Lymphoma 51:606-612, 2010.

Advani AS, Shadman M, Ali-Osman F, Barker A, Rybicki L, Kalaycio M, Sekeres MA, de Castro CM, Diehl LF, Moore JO, Beaven A, Copelan E, Sobecks R, Talea P, Rizzieri DA. A phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse. Clin Lymphoma Myeloma Leuk 10:473-476, 2010.

Advani AS, Tiu R, Saunthararajah Y, Maciejewski J, Copelan EA, Sobecks R, Sekeres MA, Bates J, Rush ML, Tripp B, Salvado A, Noon E, Howard M, Jin T, Hsi E, Egorin MJ, Lim K, Cotta CV, Price C, Kalaycio M. A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia. Leuk Res 34:1622-1626, 2010.

Agrawal D, Chak A, Champagne BJ, Marks JM, Delaney CP. Endoscopic mucosal resection with full-thickness closure for difficult polyps: a prospective clinical trial. Gastrointest Endosc 71:1082-1088, 2010.

Agrawal D, Tannous GC, Chak A. Primary malignant melanoma of the hepatic duct: a case report. Gastrointest Endosc 72:845-846, 2010.

Ahluwalia MS, Gladson CL. Progress on antiangiogenic therapy for patients with malignant glioma. J Oncol 2010:689018, 2010. PMCID: PMC2850510

Ahluwalia MS, Groot J, Liu WM, Gladson CL. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies. Cancer Lett 298:139-149, 2010.

Ahluwalia MS, Peereboom DM. Primary central nervous system lymphoma. Curr Treat Options Neurol 12:347-359, 2010.

Akiyama S, Dhavan D, Yi T. PRL-2 increases Epo and IL-3 responses in hematopoietic cells. Blood Cells Mol Dis 44:209-214, 2010. PMCID: PMC2847026

Allende DS, Desai M, Hansel DE. Primary lymphoepithelioma-like carcinoma of the ureter. Ann Diagn Pathol 14:209-214, 2010.

Amin AR, Thakur VS, Gupta K, Jackson MW, Harada H, Agarwal MK, Shin DM, Wald DN, Agarwal ML. Restoration of p53 functions protects cells from concanavalin A-induced apoptosis. Mol Cancer Ther 9:471-479, 2010.

Amling CL, Catalona WJ, Klein EA. Deciding whom to biopsy. Urol Oncol 28:542-545, 2010.

Andreias L, Borawski E, Schluchter M, Taylor HG, Klein N, Hack M. Neighborhood influences on the academic achievement of extremely low birth weight children. J Pediatr Psychol 35:275-283, 2010. PMCID: PMC2842096

Ang SK, Shoemaker LK, Davis MP. Nausea and vomiting in advanced cancer. Am J Hosp Palliat Care 27:219-225, 2010.

Anthony K, Wiencek C, Bauer C, Daly B, Anthony MK. No interruptions please: impact of a no interruption zone on medication safety in intensive care units. Crit Care Nurse 30:21-29, 2010.

Araki S, Eitel JA, Batuello CN, Bijangi-Vishehsaraei K, Xie XJ, Danielpour D, Pollok KE, Boothman DA, Mayo LD. TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. J Clin Invest 120:290-302, 2010. PMCID: PMC2798681

Arriba LN, Enerson CL, Belinson S, Novick L, Belinson J. Mexican cervical cancer screening study II: acceptability of human papillomavirus self-sampler. Int J Gynecol Cancer 20:1415-1423, 2010.

Ashing-Giwa KT, Gonzalez P, Lim JW, Chung C, Paz B, Somlo G, Wakabayashi MT. Diagnostic and therapeutic delays among a multiethnic sample of breast and cervical cancer survivors. Cancer 116:3195-3204, 2010.

Ashing-Giwa KT, Lim JW, Gonzalez P. Exploring the relationship between physical well-being and healthy lifestyle changes among European- and Latina-American breast and cervical cancer survivors. Psychooncology 19:1161-1170, 2010.

Ashing-Giwa KT, Lim JW, Tang J. Surviving cervical cancer: does health-related quality of life influence survival? Gynecol Oncol 118:35-42, 2010.

Ashing-Giwa KT, Lim JW. Exploring the association between functional strain and emotional well-being among a population-based sample of breast cancer survivors. Psychooncology 19:150-159, 2010.

Ashing-Giwa KT, Lim JW. Predicting physical quality of life among a multiethnic sample of breast cancer survivors. Qual Life Res 19:789-802, 2010.

Atkinson M, Chak A. I-Scan: chromoendoscopy without the hassle? Dig Liver Dis 42:18-19, 2010. PMCID: PMC2818582

Atkinson M, Chak A. Screening for Barrett's Esophagus. Tech Gastrointest Endosc 12:62-66, 2010. PMCID: PMC2906782

Auletta JJ, Alabran JL, Kim BG, Meyer CJ, Letterio JJ. The synthetic triterpenoid, CDDO-Me, modulates the proinflammatory response to in vivo lipopolysaccharide challenge. J Interferon Cytokine Res 30:497-508, 2010. PMCID: PMC2950060

Auletta JJ, Cooke KR, Solchaga LA, Deans RJ, Van't Hof W. Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions. Biol Blood Marrow Transplant 16:891-906, 2010.

Aydin H, Chen L, Cheng L, Vaziri S, He H, Ganapathi R, Delahunt B, Magi-Galluzzi C, Zhou M. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 34:1608-1621, 2010.

Aydin H, Zhang J, Samaratunga H, Tan N, Magi-Galluzzi C, Klein E, Jones JS, Zhou M. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management. BJU Int 105:476-480, 2010.

Bagai R, Fan W, Ma PC. ARQ-197, an oral small-molecule inhibitor of c-Met for the treatment of solid tumors. IDrugs 13:404-414, 2010.

Baird K, Cooke K, Schultz KR. Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am 57:297-322, 2010. PMCID: PMC2872081

Ballen KK, Shrestha S, Sobocinski KA, Zhang MJ, Bashey A, Bolwell BJ, Cervantes F, Devine SM, Gale RP, Gupta V, Hahn TE, Hogan WJ, Krger N, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Schiller G, Harry CS, Roy V, Wiernik PH, Horowitz MM, Giralt SA, Arora M. Outcome of transplantation for myelofibrosis. Biol Blood Marrow Transplant16:358-367, 2010. PMCID: PMC2908949

Bandyopadhyay SK, de la Motte CA, Majors AK, Strong SA. Inhibition of the phosphatidylinositol-3-kinase pathway abrogates polyinosinic:polycytidylic acid-stimulated hyaluronan-mediated human mucosal smooth muscle cell binding of U937 monocytic cells. J Interferon Cytokine Res 30:809-816, 2010. PMCID: PMC2992404

Barbastefano J, Garcia JA, Elson P, Wood LS, Lane BR, Dreicer R, Campbell SC, Rini BI. Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. BJU Int 106:1266-1269, 2010.

Bardsley MR, Horvath VJ, Asuzu DT, Lorincz A, Redelman D, Hayashi Y, Popko LN, Young DL, Lomberk GA, Urrutia RA, Farrugia G, Rubin BP, Ordog T. Kitlow stem cells cause resistance to Kit/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors. Gastroenterology 139:942-952, 2010. PMCID: PMC2933938

Barker EC, Gatbonton-Schwager TN, Han Y, Clay JE, Letterio JJ, Tochtrop GP. Bryonolic acid: A large-scale isolation and evaluation of heme oxygenase 1 expression in activated macrophages. J Nat Prod 73:1064-1068, 2010. PMCID: PMC2905313

Barnholtz-Sloan JS, Shetty PB, Guan X, Nyante SJ, Luo J, Brennan DJ, Millikan RC. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African American and younger women. Carcinogenesis 31:1417-1423, 2010. PMCID: PMC2950798

Baron ED, Malbasa CL, Santo-Domingo D, Fu P, Miller JD, Hanneman KK, Hsia AH, Oleinick NL, Colussi VC, Cooper KD. Silicon phthalocyanine (pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial. Lasers Surg Med 42:728-735, 2010.

Barron VA, Zhu H, Hinman MN, Ladd AN, Lou H. The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation. Nucleic Acids Res 38:253-264, 2010. PMCID: PMC2800208

Bartels CF, Scacheri C, White L, Scacheri PC, Bale S. Mutations in the CHD7 gene: the experience of a commercial laboratory. Genet Test Mol Biomarkers 14:881-891, 2010.

Barzi A, Pennell NA. Targeting angiogenesis in non-small cell lung cancer: agents in practice and clinical development. Eur J Clin Med Oncol 2:31-42, 2010.

Barzi A, Sekeres MA. Myelodysplastic syndromes: a practical approach to diagnosis and treatment. Cleve Clin J Med 77:37-44, 2010.

Bauer S, Parry JA, Mhlenberg T, Brown MF, Seneviratne D, Chatterjee P, Chin A, Rubin BP, Kuan SF, Fletcher JA, Duensing S, Duensing A. Proapoptotic activity of bortezomib in gastrointestinal stromal tumor cells. Cancer Res 70:150-159, 2010. PMCID: PMC2805033

Beall CM, Cavalleri GL, Deng L, Elston RC, Gao Y, Knight J, Li C, Li JC, Liang Y, McCormack M, Montgomery HE, Pan H, Robbins PA, Shianna KV, Tam SC, Tsering N, Veeramah KR, Wang W, Wangdui P, Weale ME, Xu Y, Xu Z, Yang L, Zaman MJ, Zeng C, Zhang L, Zhang X, Zhaxi P, Zheng YT. Natural selection on EPAS1 (HIF2{alpha}) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A 107:11459-11464, 2010. PMCID: PMC2895075

Beall CM, Strohl KP, Laskowski D, Hutte R, Erzurum SC. "Lower exhaled nitric oxide in acute hypobaric than in normobaric hypoxia" by T. Hemmingsson and D. Linnarsson [Respir. Physiol. Neurobiol. 169 (2009) 74-77]. Respir Physiol Neurobiol 170:211-214, 2010. PMCID: PMC2844452

Becher OJ, Hambardzumyan D, Walker TR, Helmy K, Nazarian J, Albrecht S, Hiner RL, Gall S, Huse JT, Jabado N, MacDonald TJ, Holland EC. Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. Cancer Res 70:2548-2557, 2010.

Beck AH, Lee CH, Witten DM, Gleason BC, Edris B, Espinosa I, Zhu S, Li R, Montgomery KD, Marinelli RJ, Tibshirani R, Hastie T, Jablons DM, Rubin BP, Fletcher CD, West RB, van de Rijn M. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene 29:845-854, 2010. PMCID: PMC2820592

Becka S, Zhang P, Craig SE, Lodowski DT, Wang Z, Brady-Kalnay SM. Characterization of the adhesive properties of the type IIb subfamily receptor protein tyrosine phosphatases. Cell Commun Adhes 17:34-47, 2010.

Bejanyan N, Fu AZ, Lazaryan A, Fu R, Kalaycio M, Advani A, Sobecks R, Copelan E, Maciejewski JP, Sekeres MA. Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia. Cancer 116:3614-3620, 2010.

Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao YL. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection. Int J Cancer 127:1151-1157, 2010.

Belinson SE, Belinson JL. Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries. Mol Diagn Ther 14:215-222, 2010.

Belinson SE, Wulan N, Li R, Zhang W, Rong X, Zhu Y, Wu R, Belinson JL. SNIPER: a novel assay for human papillomavirus testing among women in Guizhou, China. Int J Gynecol Cancer 20:1006-1010, 2010. PMCID: PMC2971549

Bennett KL, Lee W, Lamarre E, Zhang X, Seth R, Scharpf J, Hunt J, Eng C. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes Chromosomes Cancer 49:319-326, 2010.

Bennett KL, Mester J, Eng C. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA 304:2724-2731, 2010.

Berdis AJ. DNA polymerases: perfect enzymes for an imperfect world. Biochim Biophys Acta 1804:1029-1031, 2010.

Bernardo GM, Lozada KL, Miedler JD, Harburg G, Hewitt SC, Mosley JD, Godwin AK, Korach KS, Visvader JE, Kaestner KH, Abdul-Karim FW, Montano MM, Keri RA. FOXA1 is an essential determinant of ER{alpha} expression and mammary ductal morphogenesis. Development 137:2045-2054, 2010. PMCID: PMC2875844

Berry DC, Soltanian H, Noy N. Repression of cellular retinoic acid-binding protein II during adipocyte differentiation. J Biol Chem 285:15324-15332, 2010. PMCID: PMC2865280

Bevilacqua E, Wang X, Majumder M, Gaccioli F, Yuan CL, Wang C, Zhu X, Jordan LE, Scheuner D, Kaufman RJ, Koromilas AE, Snider MD, Holcik M, Hatzoglou M. eIF2alpha phosphorylation tips the balance to apoptosis during osmotic stress. J Biol Chem 285:17098-17111, 2010. PMCID: PMC2878040

Bhandari A, Alassi O, Rogers C, MacLennan GT. Squamous cell carcinoma of the renal pelvis. J Urol 183:2023-2024, 2010.

Bhaskaran N, Shukla S, Srivastava JK, Gupta S. Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity. Int J Mol Med 26:935-940, 2010. PMCID: PMC2982259

Bhattaram P, Penzo-Mndez A, Sock E, Colmenares C, Kaneko KJ, Vassilev A, Depamphilis ML, Wegner M, Lefebvre V. Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors. Nat Commun 1:9, 2010. PMCID: PMC2892298

Bialkowska K, Ma YQ, Bledzka K, Sossey-Alaoui K, Izem L, Zhang X, Malinin N, Qin J, Byzova T, Plow EF. The integrin co-activator kindlin-3 is expressed and functional in a non-hematopoietic cell, the endothelial cell. J Biol Chem 285:18640-18649, 2010. PMCID: PMC2881789

Bianco FJ Jr, Vickers AJ, Cronin AM, Klein EA, Eastham JA, Pontes JE, Scardino PT. Variations among experienced surgeons in cancer control after open radical prostatectomy. J Urol 183:977-982, 2010.

Bianco FJ, Cronin AM, Klein EA, Pontes JE, Scardino PT, Vickers AJ. Fellowship training as a modifier of the surgical learning curve. Acad Med 85:863-868, 2010. PMCID: PMC2929848

Bidros DS, Liu JK, Vogelbaum MA. Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol 6:117-125, 2010.

Bieghs V, Wouters K, Van Gorp PJ, Gijbels MJ, De Winther MP, Binder CJ, Ltjohann D, Febbraio M, Moore KJ, Van Bilsen M, Hofker MH, Shiri-Sverdlov R. Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology 138:2477-2486, 2486.e1-3, 2010.

Bishop MR, Dean RM, Steinberg SM, Odom J, Pollack SM, Pavletic SZ, Sportes C, Gress RE, Fowler DH. Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. Cancer 116:852-862, 2010.

Blanke CD, Chansky K, Christman KL, Hundahl SA, Issell BF, Van Veldhuizen PJ Jr, Budd GT, Abbruzzese JL, Macdonald JS. S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach. Am J Clin Oncol 33:117-120, 2010. PMCID: PMC2967385

Bledzka K, Bialkowska K, Nie H, Qin J, Byzova T, Wu C, Plow EF, Ma YQ. Tyrosine phosphorylation of integrin beta3 regulates kindlin-2 binding and integrin activation. J Biol Chem 285:30370-30374, 2010. PMCID: PMC2945529

Blum AE, Walsh BC, Dubyak GR. Extracellular osmolarity modulates G protein-coupled receptor-dependent ATP release from 1321N1 astrocytoma cells. Am J Physiol Cell Physiol 298:C386-396, 2010. PMCID: PMC2822496

Blum KA, Jung SH, Johnson JL, Lin TS, Hsi ED, Lucas DM, Byrd JC, Cheson BD, Bartlett NL; Cancer and Leukemia Group B. Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an Fc?RIIIa-158 V/F polymorphism. Ann Oncol 21:2246-2254, 2010. PMCID: PMC2962257

Bonda DJ, Lee HP, Kudo W, Zhu X, Smith MA, Lee HG. Pathological implications of cell cycle re-entry in Alzheimer disease. Expert Rev Mol Med12:e19, 2010. PMCID: PMC2922901

Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, Zhu X, Smith MA. Novel therapeutics for Alzheimer's disease: an update. Curr Opin Drug Discov Devel 13:235-246, 2010. PMCID: PMC2931269

Bonda DJ, Wang X, Perry G, Smith MA, Zhu X. Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies. Drugs Aging 27:181-192, 2010. PMCID: PMC2923854

Bonfield TL, Caplan AI. Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. Discov Med 9:337-345, 2010.

Borawski EA, Brooks A, Colabianchi N, Trapl ES, Przepyszny KA, Shaw N, Danosky L. Adult use of cigars, little cigars, and cigarillos in Cuyahoga County, Ohio: a cross-sectional study. Nicotine Tob Res 12:669-673, 2010.

Borden EC, Raghavan D. Personalizing medicine for cancer: the next decade. Nat Rev Drug Discov 9:343-344, 2010.

Bowman KF, Rose JH, Deimling GT, Kypriotakis G, O'Toole EE. Primary care physicians' involvement in the cancer care of older long-term survivors. J Aging Health 22:673-686, 2010.

Bradley CJ, Dahman B, Bataki PM, Koroukian S. Incremental value of using Medicaid claim files to study comorbid conditions and treatments in dually eligible beneficiaries. Med Care 48:79-84, 2010.

Bradley KT, Arber DA, Brown MS, Chang CC, Coupland SE, de Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Lill MC, McClure SP, Medeiros LJ, Perkins SL, Hussong JW. Protocol for the examination of specimens from patients with hematopoietic neoplasms of the ocular adnexa. Arch Pathol Lab Med 134:336-340, 2010.

Brawley OW, Newman LA, Raghavan D. Reply to M. Moore et al [Patient comorbidities and behaviour once diagnosed are major contributors to disparities in cancer health outcomes]. J Clin Oncol 28:e38, 2010.

Breckenridge MT, Egelhoff TT, Baskaran H. A microfluidic imaging chamber for the direct observation of chemotactic transmigration. Biomed Microdevices 12:543-553, 2010. PMCID: PMC2886973

Broderick SR, Golas BJ, Pham D, Towe CW, Talbot SG, Kaufman A, Bains S, Huryn LA, Yonekawa Y, Carlson D, Hambardzumyan D, Ramanathan Y, Singh B. SCCRO promotes glioma formation and malignant progression in mice. Neoplasia 12:476-484, 2010. PMCID: PMC2887088

Broniatowski M, Grundfest-Broniatowski S, Hadley AJ, Shah NS, Barbu AM, Phillipbar SA, Strohl KP, Tucker HM, Tyler DJ. Improvement of respiratory compromise through abductor reinnervation and pacing in a patient with bilateral vocal fold impairment. Laryngoscope 120:76-83, 2010.

Broome AM, Bhavsar N, Ramamurthy G, Newton G, Basilion JP. Expanding the utility of beta-galactosidase complementation: piece by piece. Mol Pharm 7:60-74, 2010. PMCID: PMC2835542

Brunel FM, Lewis JD, Destito G, Steinmetz NF, Manchester M, Stuhlmann H, Dawson PE. Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett 10:1093-1097, 2010.

Brunstein CG, Laughlin MJ. Extending cord blood transplant to adults: dealing with problems and results overall. Semin Hematol 47:86-96, 2010.

Bukowski RM, Stadler WM, McDermott DF, Dutcher JP, Knox JJ, Miller WH Jr, Hainsworth JD, Henderson CA, Hajdenberg J, Kindwall-Keller TL, Ernstoff MS, Drabkin HA, Curti BD, Chu L, Ryan CW, Hotte SJ, Xia C, Cupit L, Figlin RA. Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program. Oncology 78:340-347, 2010.

Bukowski RM, Yasothan U, Kirkpatrick P. Pazopanib. Nat Rev Drug Discov 9:17-18, 2010.

Bukowski RM. Is pazopanib safe and efficacious in patients with metastatic renal cell carcinoma? Curr Oncol Rep 12:77-79, 2010.

Bukowski RM. Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab. Cancer Manag Res 2:83-96, 2010.

Bukowski RM. Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinoma. Expert Rev Anticancer Ther 10:635-645, 2010.

Bukowski RM. Systemic therapy for metastatic renal cell carcinoma in treatment nave patients: a risk-based approach. Expert Opin Pharmacother 11:2351-2362, 2010.

Bulgar AD, Snell M, Donze JR, Kirkland EB, Li L, Yang S, Xu Y, Gerson SL, Liu L. Targeting base excision repair suggests a new therapeutic strategy of fludarabine for the treatment of chronic lymphocytic leukemia. Leukemia 24:1795-1799, 2010.

Burden-Gulley SM, Gates TJ, Burgoyne AM, Cutter JL, Lodowski DT, Robinson S, Sloan AE, Miller RH, Basilion JP, Brady-Kalnay SM. A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu. Neoplasia 12:305-316, 2010. PMCID: PMC2847738

Burden-Gulley SM, Gates TJ, Craig SE, Gupta M, Brady-Kalnay SM. Stimulation of N-cadherin-dependent neurite outgrowth by small molecule peptide mimetic agonists of the N-cadherin HAV motif. Peptides 31:842-849, 2010.

Burg MA, Zebrack B, Walsh K, Maramaldi P, Lim JW, Smolinski KM, Lawson K. Barriers to accessing quality health care for cancer patients: a survey of members of the association of oncology social work. Soc Work Health Care 49:38-52, 2010.

Burrage LC, Baskin-Hill AE, Sinasac DS, Singer JB, Croniger CM, Kirby A, Kulbokas EJ, Daly MJ, Lander ES, Broman KW, Nadeau JH. Genetic resistance to diet-induced obesity in chromosome substitution strains of mice. Mamm Genome 21:115-129, 2010.

Busch SA, Horn KP, Cuascut FX, Hawthorne AL, Bai L, Miller RH, Silver J. Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J Neurosci 30:255-265, 2010. PMCID: PMC2823089

Cai GQ, Zheng A, Tang Q, White ES, Chou CF, Gladson CL, Olman MA, Ding Q. Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts. Exp Cell Res 316:1600-1609, 2010. PMCID: PMC2871958

Cai R, Barnett GH, Novak E, Chao ST, Suh JH. Principal risk of peritumoral edema after stereotactic radiosurgery for intracranial meningioma is tumor-brain contact interface area. Neurosurgery 66:513-522, 2010.

Caimi PF, Barr PM, Berger NA, Lazarus HM. Non-Hodgkin's lymphoma in the elderly. Drugs Aging 27:211-238, 2010.

Caimi PF, Reese J, Lee Z, Lazarus HM. Emerging therapeutic approaches for multipotent mesenchymal stromal cells. Curr Opin Hematol 17:505-513, 2010.

Cakmak A, Ozsoyoglu G, Hanson RW. Querying metabolism under different physiological constraints. J Bioinform Comput Biol 8:247-293, 2010.

Campbell SC, Bhoopalam N, Moritz TE, Pandya M, Iyer P, Vanveldhuizen P, Ellis NK, Thottapurathu L, Garewal H, Warren SR, Friedman N, Reda DJ. The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis. Urology 75:1138-1143, 2010.

Campbell SC, Faraday M, Uzzo RG. Small renal mass. N Engl J Med 362:2334; author reply 2334-2335, 2010.

Campbell SC, Lane BR. Editorial comment [Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma]. J Urol 183:485, 2010.

Campbell SC, Rini BI. Editorial comment [Effect of collecting duct histology on renal cell cancer outcome]. J Urol 182:2599-2600, 2010.

Campbell SC. Editorial comment [Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment]. J Urol 184:1881, 2010.

Cannady SB, Lee WT, Scharpf J, Lorenz RR, Wood BG, Strome M, Lavertu P, Esclamado RM, Saxton JP, Adelstein DJ. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. Head Neck 32:348-356, 2010.

Cantatore-Francis JL, Cohen-Pfeffer J, Balwani M, Kahn P, Lazarus HM, Desnick RJ, Schaffer JV. Hepatoerythropoietic porphyria misdiagnosed as child abuse: cutaneous, arthritic, and hematologic manifestations in siblings with a novel UROD mutation. Arch Dermatol 146:529-533, 2010.

Cao Y, Lathia JD, Eyler CE, Wu Q, Li Z, Wang H, McLendon RE, Hjelmeland AB, Rich JN. Erythropoietin receptor signaling through STAT3 is required for glioma stem cell maintenance. Genes Cancer 1:50-61, 2010. PMCID: PMC2906804

Caplan AI. What's in a name? Tissue Eng Part A 16:2415-2417, 2010.

Castellino RC, Barwick BG, Schniederjan M, Buss MC, Becher O, Hambardzumyan D, Macdonald TJ, Brat DJ, Durden DL. Heterozygosity for Pten promotes tumorigenesis in a mouse model of medulloblastoma. PLoS One 5:e10849, 2010. PMCID: PMC2877103

Chakravarti R, Aulak KS, Fox PL, Stuehr DJ. GAPDH regulates cellular heme insertion into inducible nitric oxide synthase. Proc Natl Acad Sci U S A 107:18004-18009, 2010. PMCID: PMC2964200

Chalmers JJ, Xiong Y, Jin X, Shao M, Tong X, Farag S, Zborowski M. Quantification of non-specific binding of magnetic micro- and nanoparticles using cell tracking velocimetry: Implication for magnetic cell separation and detection. Biotechnol Bioeng 105:1078-1093, 2010.

Chamnongpol S, Maroney PA, Nilsen TW. A rapid, quantitative assay for direct detection of microRNAs and other small RNAs using splinted ligation. Methods Mol Biol 667:3-17, 2010.

Chan HY, Grossman AB, Bukowski RM. Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors. Adv Ther 27:495-511, 2010.

Chao J, Budd GT, Chu P, Frankel P, Garcia D, Junqueira M, Loera S, Somlo G, Sato J, Chow WA. Phase II clinical trial of imatinib mesylate in therapy of KIT and/or PDGFRalpha-expressing Ewing sarcoma family of tumors and desmoplastic small round cell tumors. Anticancer Res 30:547-552, 2010.

Chattopadhyay S, Marques JT, Yamashita M, Peters KL, Smith K, Desai A, Williams BR, Sen GC. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J 29:1762-1773, 2010. PMCID: PMC2876960

Chaudhury A, Chander P, Howe PH. Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: focus on hnRNP E1's multifunctional regulatory roles. RNA 16:1449-1462, 2010. PMCID: PMC2905745

Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 12:286-293, 2010. PMCID: PMC2830561

Chen X, Saidel GM. Modeling of laser coagulation of tissue with MRI temperature monitoring. J Biomech Eng 132:064503, 2010.

Chen Y, Li X, Li J. A novel approach for haplotype-based association analysis using family data. BMC Bioinformatics 11(Suppl 1):S45, 2010.

Cheng I, Plummer SJ, Neslund-Dudas C, Klein EA, Casey G, Rybicki BA, Witte JS. Prostate cancer susceptibility variants confer increased risk of disease progression. Cancer Epidemiol Biomarkers Prev 19:2124-2132, 2010. PMCID: PMC2950095

Cheng L, Bao S, Rich JN. Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem Pharmacol 80:654-665, 2010. PMCID: PMC2897968

Cheng L, Davidson DD, Maclennan GT, Williamson SR, Zhang S, Koch MO, Montironi R, Lopez-Beltran A. The origins of urothelial carcinoma. Expert Rev Anticancer Ther 10:865-880, 2010.

Cheng L, Williamson SR, Zhang S, Maclennan GT, Montironi R, Lopez-Beltran A. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy. Expert Rev Anticancer Ther 10:843-864, 2010.

Cheng Y, Samia AC, Li J, Kenney ME, Resnick A, Burda C. Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface. Langmuir 26:2248-2255, 2010.

Chenoweth JG, McKay RD, Tesar PJ. Epiblast stem cells contribute new insight into pluripotency and gastrulation. Dev Growth Differ 52:293-301, 2010.

Chenoweth JG, Tesar PJ. Isolation and maintenance of mouse epiblast stem cells. Methods Mol Biol 636:25-44, 2010.

Chigurupati S, Venkataraman R, Barrera D, Naganathan A, Madan M, Paul L, Pattisapu JV, Kyriazis GA, Sugaya K, Bushnev S, Lathia JD, Rich JN, Chan SL. Receptor channel TRPC6 is a key mediator of notch-driven glioblastoma growth and invasiveness. Cancer Res 70:418-427, 2010.

Chikamori K, Grozav AG, Kozuki T, Grabowski D, Ganapathi R, Ganapathi MK. DNA topoisomerase II enzymes as molecular targets for cancer chemotherapy. Curr Cancer Drug Targets 10:758-771, 2010.

Ching CB, Hansel DE. Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway. Lab Invest 90:1406-1414, 2010.

Chiu SM, Xue LY, Lam M, Rodriguez ME, Zhang P, Kenney ME, Nieminen AL, Oleinick NL. A requirement for bid for induction of apoptosis by photodynamic therapy with a lysosome- but not a mitochondrion-targeted photosensitizer. Photochem Photobiol 86:1161-1173, 2010. PMCID: PMC2974808

Cho EI, Tan C, Koski GK, Cohen PA, Shu S, Lee WT. Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines. Head Neck 32:700-707, 2010.

Chow E, James J, Barsevick A, Hartsell W, Ratcliffe S, Scarantino C, Ivker R, Roach M, Suh J, Petersen I, Konski A, Demas W, Bruner D. Functional interference clusters in cancer patients with bone metastases: a secondary analysis of RTOG 9714. Int J Radiat Oncol Biol Phys 76:1507-1511, 2010. PMCID: PMC2846210

Chowdhury SA, Koyutrk M. Identification of coordinately dysregulated subnetworks in complex phenotypes. Pac Symp Biocomput 133-144, 2010.

Chumakov SP, Kravchenko JE, Prassolov VS, Frolova EI, Chumakov PM. Efficient downregulation of multiple mRNA targets with a single shRNA-expressing lentiviral vector. Plasmid 63:143-149 2010. PMCID: PMC2849729

Cianciola NL, Carlin CR. Adenovirus RIDalpha protein reveals novel autophagic mechanism that regulates cholesterol homeostasis. Autophagy 6:296-298, 2010. PMCID: PMC2779231

Ciezki JP, Reddy CA, Stephenson AJ, Angermeier K, Ulchaker J, Altman A, Chehade N, Klein EA. The importance of serum prostate-specific antigen testing frequency in assessing biochemical and clinical failure after prostate cancer treatment. Urology 75:467-471, 2010.

Cipriano R, Patton JT, Mayo LD, Jackson MW. Inactivation of p53 signaling by p73 or PTEN ablation results in a transformed phenotype that remains susceptible to Nutlin-3 mediated apoptosis. Cell Cycle 9:1373-1379, 2010.

Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ. The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. Biol Blood Marrow Transplant 16:253-262, 2010. PMCID: PMC2952392

Cooke DT, Pagani FD, Kaul DR, Cooke KR, Lau CL, Riddell J 4th. Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole. Mycoses 53:163-167, 2010.

Cooke KR. A role for lymphotoxin in GVHD and GVL. Blood 115:3-4, 2010.

Cortes JE, Baccarani M, Guilhot F, Druker BJ, Branford S, Kim DW, Pane F, Pasquini R, Goldberg SL, Kalaycio M, Moiraghi B, Rowe JM, Tothova E, De Souza C, Rudoltz M, Yu R, Krahnke T, Kantarjian HM, Radich JP, Hughes TP. Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine kinase inhibitor optimization and selectivity study. J Clin Oncol 28:424-430, 2010.

Crabtree BF, Nutting PA, Miller WL, Stange KC, Stewart EE, Jan CR. Summary of the National Demonstration Project and recommendations for the patient-centered medical home. Ann Fam Med 8 Suppl 1:S80-90, 2010. PMCID: PMC2885727

Cramer JD, Fu P, Harth KC, Margevicius S, Wilhelm SM. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry. Surgery 148:1147-1153, 2010.

Cripe LD, Uno H, Paietta EM, Litzow MR, Ketterling RP, Bennett JM, Rowe JM, Lazarus HM, Luger S, Tallman MS. Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled, trial of the Eastern Cooperative Oncology Group (ECOG 3999). Blood 116:4077-4085, 2010. PMCID: PMC2993615

Culp PA, Choi D, Zhang Y, Yin J, Seto P, Ybarra SE, Su M, Sho M, Steinle R, Wong MH, Evangelista F, Grove J, Cardenas M, James M, Hsi ED, Chao DT, Powers DB, Ramakrishnan V, Dubridge R. Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms. Clin Cancer Res 16:497-508, 2010.

Cummings LC, Cooper GS. Editorial: detection of small polyps: much ado about nothing? Am J Gastroenterol 105:2586-2587, 2010.

Cummins NW, Jiang W, McGinty J, Bren GD, Bosch RJ, Landay A, Deeks SG, Martin JN, Douek D, Lederman MM, Brenchley J, Badley AD. Intracellular Casp8p41 content is inversely associated with CD4 T cell count. J Infect Dis 202:386-391, 2010. PMCID: PMC2906377

Dai X, Gao Y, Xu Z, Cui X, Liu J, Li Y, Xu H, Liu M, Wang QK, Liu JY. Identification of a novel genetic locus on chromosome 8p21.1-q11.23 for idiopathic basal ganglia calcification. Am J Med Genet B Neuropsychiatr Genet 153B:1305-1310, 2010.

Dalton JE, Kattan MW. Recent advances in evaluating the prognostic value of a marker. Scand J Clin Lab Invest 70:59-62, 2010.

Daly AF, Tichomirowa MA, Petrossians P, Helivaara E, Jaffrain-Rea ML, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A, Cazabat L, De Menis E, Montaana CF, Raverot G, Weil RJ, et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95:E373-E383, 2010.

Daly BJ, Douglas SL, O'Toole E, Gordon NH, Hejal R, Peerless J, Rowbottom J, Garland A, Lilly C, Wiencek C, Hickman R. Effectiveness trial of an intensive communication structure for families of long-stay ICU patients. Chest 138:1340-1348, 2010. PMCID: PMC2998207

Das D, Luo X, Singh A, Gu Y, Ghosh S, Mukhopadhyay CK, Chen SG, Sy MS, Kong Q, Singh N. Paradoxical role of prion protein aggregates in redox-iron induced toxicity. PLoS One 5(7):e11420, 2010. PMCID: PMC2897850

Das R, Plow EF. A new function for old drugs. Cell Cycle 9:638-639, 2010.

Datta S, Novotny M, Pavicic PG Jr, Zhao C, Herjan T, Hartupee J, Hamilton T. IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence. J Immunol 184:1484-1491, 2010. PMCID: PMC2829999

Davidson JE, Daly BJ, Agan D, Brady NR, Higgins PA. Facilitated sensemaking: a feasibility study for the provision of a family support program in the intensive care unit. Crit Care Nurs Q 33:177-189, 2010.

Davis M. Larval therapy for leg ulcers. J Pain Palliat Care Pharmacother 24:58-59, 2010.

Davis M. Patients perceptions of acceptable pain relief. J Pain Palliat Care Pharmacother 24:60-61, 2010.

Davis M. Promethazine inhibits herg channels. J Pain Palliat Care Pharmacother 24:59-60, 2010.

Davis MP, Hallerberg G; Palliative Medicine Study Group of the Multinational Association of Supportive Care in Cancer. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manage 39:756-767, 2010.

Davis MP, McPherson ML. Tabling hydromorphone: do we have it right? J Palliat Med 13:365-366, 2010.

Davis MP, Walsh D. Mechanisms of fatigue. J Support Oncol 8:164-174, 2010.

Davis MP. Opioid receptor targeting ligands for pain management: a review and update. Exp Opin Drug Discov 5:1007-1022, 2010.

Davis MP. Re: Establishing "best practices" for opioid rotation. J Pain Symptom Manage 39:e1-e2, 2010.

Davis MP. Recent advances in the treatment of pain. F1000 Med Rep 2:63, 2010.

Davis MP. Recent development in therapeutics for breakthrough pain. Expert Rev Neurother 10:757-773, 2010.

Dazard JE, Rao JS. Local sparse bump hunting. J Comput Graph Stat 19:900-929, 2010.

Dean RM, Pohlman B, Sweetenham JW, Sobecks RM, Kalaycio ME, Smith SD, Copelan EA, Andresen S, Rybicki LA, Curtis J, Bolwell BJ. Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide. Br J Haematol 148:226-234, 2010.

Delaney CP, Champagne BJ, Marks JM, Sanuk L, Ermlich B, Chak A. Tissue apposition system: new technology to minimize surgery for endoscopically unresectable colonic polyps. Surg Endosc 24:3113-3118, 2010.

Den RB, Doemer A, Kubicek G, Bednarz G, Galvin JM, Keane WM, Xiao Y, Machtay M. Daily image guidance with cone-beam computed tomography for head and neck cancer intensity-modulated radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys 76:1353-1359, 2010.

Deng CX, Exner A. Image-guided therapeutics. Mol Pharm 7:1-2, 2010.

Derakhshan JJ, Griswold MA, Nour SG, Sunshine JL, Duerk JL. Characterization and reduction of saturation banding in multiplanar coherent and incoherent steady-state imaging. Magn Reson Med 63:1415-1421, 2010.

Devireddy LR, Hart DO, Goetz DH, Green MR. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell 141:1006-1017, 2010. PMCID: PMC2910436

Dewal N, Freedman ML, Laframboise T, Pe'er I. Power to detect selective allelic amplification in genome-wide scans of tumor data. Bioinformatics 26:518-528, 2010. PMCID: PMC2852215

Diede SJ, Guenthoer J, Geng LN, Mahoney SE, Marotta M, Olson JM, Tanaka H, Tapscott SJ. DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences. Proc Natl Acad Sci U S A 107:234-239, 2010. PMCID: PMC2806770

Diehl K, Litaker DG, Greinert R, Zimmermann S, Breitbart EW, Schneider S. The prevalence of current sunbed use and user characteristics: the SUN-Study 2008. Int J Public Health 55:513-516, 2010.

Do JS, Fink PJ, Li L, Spolski R, Robinson J, Leonard WJ, Letterio JJ, Min B. Cutting edge: spontaneous development of IL-17-Producing gammadelta T cells in the thymus occurs via a TGF-beta1-dependent mechanism. J Immunol 184:1675-1679, 2010. PMCID: PMC2844788

Doane TL, Cheng Y, Babar A, Hill RJ, Burda C. Electrophoretic mobilities of PEGylated gold NPs. J Am Chem Soc 132:15624-15631, 2010.

Donahue TR, Kattan MW, Nelson SD, Tap WD, Eilber FR, Eilber FC. Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram. Cancer 116:3883-3891, 2010.

Donato LJ, Noy N. Fluorescence-based technique for analyzing retinoic acid. Methods Mol Biol 652:177-187, 2010.

Dong B, Silverman RH. Androgen stimulates transcription and replication of XMRV (Xenotropic Murine Leukemia Virus-Related Virus). J Virol 84:1648-1651, 2010. PMCID: PMC2812331

Donovan L, Welford SM, Haaga J, Lamanna J, Strohl KP. Hypoxia--implications for pharmaceutical developments. Sleep Breath 14:291-298, 2010.

Douglas SL, Daly BJ, O'Toole E, Hickman RL Jr. Depression among white and nonwhite caregivers of the chronically critically ill. J Crit Care 25:364.e11-19, 2010. PMCID: PMC2883690

Dowd DR, Macdonald PN. The 1,25-dihydroxyvitamin D(3)-independent actions of the vitamin D receptor in skin. J Steroid Biochem Mol Biol 121:317-321, 2010.

Dowlati A. Hunting and trapping the vascular endothelial growth factor. J Clin Oncol 28:185-187, 2010.

Drage MG, Tsai HC, Pecora ND, Cheng TY, Arida AR, Shukla S, Rojas RE, Seshadri C, Moody DB, Boom WH, Sacchettini JC, Harding CV. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2. Nat Struct Mol Biol 17:1088-1095, 2010. PMCID: PMC2933325

Drake BF, Shelton RC, Gilligan T, Allen JD. A church-based intervention to promote informed decision making for prostate cancer screening among African American men. J Natl Med Assoc 102:164-171, 2010. PMCID: PMC2913684

Dreicer R. Androgen deprivation therapy in patients with advanced prostate cancer. J Support Oncol 8:209-211, 2010.

Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN. Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults. Crit Rev Oncol Hematol 73:68-91, 2010.

Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int 106:462-469, 2010.

Du Y, Fryzek J, Sekeres MA, Taioli E. Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leuk Res 34:1-5, 2010.

Du Z, Song J, Wang Y, Zhao Y, Guda K, Yang S, Kao HY, Xu Y, Willis J, Markowitz SD, Sedwick D, Ewing RM, Wang Z. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal 3:ra80, 2010.

Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, Kamble R, Copelan E, de Lima M, Gupta V, Keating A, Lazarus HM, Litzow MR, Marks DI, Maziarz RT, Rizzieri DA, Schiller G, Schultz KR, Tallman MS, Weisdorf D. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol 28:3730-3738, 2010. PMCID: PMC2917308

Dwyer-Nield LD, McQuillan J, Hill-Baskin A, Radcliffe RA, You M, Nadeau JH, Malkinson AM. Epistatic interactions govern chemically-induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J-ChrA/J chromosome substitution strains. Int J Cancer 126:125-132, 2010. PMCID: PMC2783521

Earnshaw SR, McDade CL, Black LK, Bell CF, Kattan MW. Cost effectiveness of 5-alpha reductase Inhibitors for the prevention of prostate cancer in multiple patient populations. Pharmacoeconomics 28:489-505, 2010.

Ebrahem Q, Chaurasia SS, Vasanji A, Qi JH, Klenotic PA, Cutler A, Asosingh K, Erzurum S, Anand-Apte B. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo. Am J Pathol 176:496-503, 2010. PMCID: PMC2797907

Elmunzer BJ, Pollack MJ, Trunzo JA, Schomisch SJ, Wong RC, Faulx AL, Isenberg GA, Ponsky JL, Marks JM, Chak A. Initial evaluation of a novel, prototype, forward-viewing echoendoscope in a porcine arterial bleeding model. Gastrointest Endosc 72:611-614, 2010.

Eng C. Common alleles of predisposition in endocrine neoplasia. Curr Opin Genet Dev 20:251-256, 2010.

Eng C. Mendelian genetics of rare--and not so rare--cancers. Ann N Y Acad Sci 1214:70-82, 2010.

Eng K, Scouten-Ponticelli SK, Sutton M, Berdis A. Selective inhibition of DNA replicase assembly by a non-natural nucleotide: exploiting the structural diversity of ATP-binding sites. ACS Chem Biol 5:183-194, 2010.

Eng KT, Berdis AJ. A novel non-natural nucleoside that influences P-glycoprotein activity and mediates drug resistance. Biochemistry 49:1640-1648, 2010.

Epstein RM, Fiscella K, Lesser CS, Stange KC. Why the nation needs a policy push on patient-centered health care. Health Aff (Millwood) 29:1489-1495, 2010.

Erlic Z, Hoffmann MM, Sullivan M, Franke G, Peczkowska M, Harsch I, Schott M, Gabbert HE, Valimki M, Preuss SF, Hasse-Lazar K, Waligorski D, Robledo M, Januszewicz A, Eng C, Neumann HP. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and Von Hippel-Lindau Syndrome. J Clin Endocrinol Metab 95:308-313, 2010. PMCID: PMC2805484

Erlic Z, Ploeckinger U, Cascon A, Hoffmann MM, von Duecker L, Winter A, Kammel G, Bacher J, Sullivan M, Isermann B, Fischer L, Raffel A, Knoefel WT, Schott M, Baumann T, Schaefer O, Keck T, Baum RP, Milos I, Muresan M, Peczkowska M, Januszewicz A, Cupisti K, Tnjes A, Fasshauer M, Langrehr J, von Wussow P, Agaimy A, Schlimok G, Lamberts R, Wiech T, Schmid KW, Weber A, Nunez M, Robledo M, Eng C, Neumann HP; VHL-ICT Consortium; German NET Registry. Systematic comparison of sporadic and syndromic pancreatic islet cell tumors. Endocr Relat Cancer 17:875-883, 2010.

Esposito A, Suedekum B, Liu J, An F, Lass J, Strainic MG, Lin F, Heeger P, Medof ME. Decay accelerating factor is essential for successful corneal engraftment. Am J Transplant 10:527-534, 2010.

Fader AN, Rasool N, Vaziri SA, Kozuki T, Faber PW, Elson P, Biscotti CV, Michener CM, Rose PG, Rojas-Espaillat L, Belinson JL, Ganapathi MK, Ganapathi R. CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes. Anticancer Res 30:4791-4798, 2010.

Fagnan LJ, Davis M, Deyo RA, Werner JJ, Stange KC. Linking practice-based research networks and Clinical and Translational Science Awards: new opportunities for community engagement by academic health centers. Acad Med 85:476-483, 2010.

Fairman-Williams ME, Guenther UP, Jankowsky E. SF1 and SF2 helicases: family matters. Curr Opin Struct Biol 20:313-324, 2010. PMCID: PMC2916977

Falzarano SM, Navas M, Simmerman K, Klein EA, Rubin MA, Zhou M, Magi-Galluzzi C. ERG rearrangement is present in a subset of transition zone prostatic tumors. Mod Pathol 23:1499-1506, 2010.

Fang YH, Asthana P, Salinas C, Huang HM, Muzic RF Jr. Integrated software environment based on COMKAT for analyzing tracer pharmacokinetics with molecular imaging. J Nucl Med 51:77-84, 2010.

Farley J, Rose PG. Trial design for evaluation of novel targeted therapies. Gynecol Oncol 116:173-176, 2010.

Feng Q, Vannaprasaht S, Peng Y, Angsuthum S, Avihingsanon Y, Yee VC, Tassaneeyakul W, Weinshilboum RM.Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme. Biochem Pharmacol 79:1053-1061, 2010. PMCID: PMC2815203

Ferenczi K, Ohtola J, Aubert P, Kessler M, Sugiyama H, Somani AK, Gilliam AC, Chen JZ, Yeh I, Matsuyama S, McCormick TS, Cooper KD. Malignant T cells in cutaneous T-cell lymphoma lesions contain decreased levels of the anti-apoptotic protein Ku70. Br J Dermatol 163:564-571, 2010.

Finney MR, Fanning LR, Joseph ME, Goldberg JL, Greco NJ, Bhakta S, Winter DG, Forster M, Scheid PE, Sabe M, Pompili VJ, Laughlin MJ. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo. Cytotherapy 12:67-78, 2010.

Fiocchi C. Current perspectives in inflammatory bowel disease: stress response and autophagy, host-microbe mutualism, immune duality and plasticity, and early versus late disease. Curr Opin Gastroenterol 26:299-301, 2010.

Fogh S, Machtay M, Werner-Wasik M, Curran WJ Jr, Bonanni R, Axelrod R, Andrews D, Dicker AP. Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies. Int J Radiat Oncol Biol Phys 77:1009-1016, 2010.

Foster TH, Giesselman BR, Hu R, Kenney ME, Mitra S. Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals. Transl Oncol 3:135-141, 2010. PMCID: PMC2847321

Francis LE, Worthington J, Kypriotakis G, Rose JH. Relationship quality and burden among caregivers for late-stage cancer patients. Support Care Cancer 18:1429-1436, 2010.

Friedberg JW, Sharman J, Sweetenham J, Johnston PB, Vose JM, Lacasce A, Schaefer-Cutillo J, De Vos S, Sinha R, Leonard JP, Cripe LD, Gregory SA, Sterba MP, Lowe AM, Levy R, Shipp MA. Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood 115:2578-2585, 2010. PMCID: PMC2852362

Friedman LC, Barber CR, Chang J, Tham YL, Kalidas M, Rimawi MF, Dulay MF, Elledge R. Self-blame, self-forgiveness, and spirituality in breast cancer survivors in a public sector setting. J Cancer Educ 25:343-348, 2010.

Frisa PS, Jacobberger JW. Cytometry of chromatin bound Mcm6 and PCNA identifies two states in G1 that are separated functionally by the G1 restriction point. BMC Cell Biol 11:26, 2010. PMCID: PMC2882901

Fu AZ, Cantor SB, Kattan MW. Use of nomograms for personalized decision-analytic recommendations. Med Decis Making 30:267-274, 2010.

Funderburg N, Kalinowska M, Eason J, Goodrich J, Heera J, Mayer H, Rajicic N, Valdez H, Lederman MM. Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients. PLoS One 5:e13188, 2010. PMCID: PMC2950842

Funderburg NT, Mayne E, Sieg SF, Asaad R, Jiang W, Kalinowska M, Luciano AA, Stevens W, Rodriguez B, Brenchley JM, Douek DC, Lederman MM. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 115:161-167, 2010. PMCID: PMC2808148

Gao C, Liu Y, Lam M, Kao HY. Histone deacetylase 7 (HDAC7) regulates myocyte migration and differentiation. Biochim Biophys Acta 1803:1186-1197, 2010. PMCID: PMC2922493

Garcia JA, Hutson TE, Elson P, Cowey CL, Gilligan T, Nemec C, Dreicer R, Bukowski RM, Rini BI. Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab. Cancer 116:5383-5390, 2010.

George S, Brenner A, Sarantopoulos J, Bukowski RM. RANK ligand: effects of inhibition. Curr Oncol Rep 12:80-86, 2010.

George S, Shah SN, Bukowski RM. Stable disease in renal cell carcinoma after using signal transduction inhibitors. Rev Recent Clin Trials 5:117-122, 2010.

Gill HS. Evaluating the efficacy of tryptophan fluorescence and absorbance as a selection tool for identifying protein crystals. Acta Crystallogr Sect F Struct Biol Cryst Commun 66(Pt 3):364-372, 2010. PMCID: PMC2833058

Gilligan TD, Hayes DF, Seidenfeld J, Temin S. ASCO clinical practice guideline on uses of serum tumor markers in adult males with germ cell tumors. J Oncol Pract 6:199-202, 2010. PMCID: PMC2900872

Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R, Hayes DF. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol 28:3388-3404, 2010.

Giltiay NV, Lu Y, Allman D, Jrgensen TN, Li X. The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation. J Immunol 185:99-109, 2010.

Gladson CL, Prayson RA, Liu WM. The pathobiology of glioma tumors. Annu Rev Pathol 5:33-50, 2010. PMCID: PMC2887670

Gonzalo P, Guadamillas MC, Hernndez-Riquer MV, Polln A, Grande-Garca A, Bartolom RA, Vasanji A, Ambrogio C, Chiarle R, Teixid J, Risteli J, Apte SS, del Pozo MA, Arroyo AG. MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. Dev Cell 18:77-89, 2010. PMCID: PMC2822729

Good M, Albert JM, Anderson GC, Wotman S, Cong X, Lane D, Ahn S. Supplementing relaxation and music for pain after surgery. Nurs Res 59:259-269, 2010.

Gorbachev AV, Fairchild RL. CD4+CD25+ regulatory T cells utilize FasL as a mechanism to restrict DC priming functions in cutaneous immune responses. Eur J Immunol 40:2006-2015, 2010. PMCID: PMC2920369

Gorbacheva V, Fan R, Li X, Valujskikh A. Interleukin-17 promotes early allograft inflammation. Am J Pathol 177:1265-1273, 2010. PMCID: PMC2928960

Gordon NH, Siminoff LA. Measuring quality of life of long-term breast cancer survivors: the long term quality of life-breast cancer (LTQOL-BC) scale. J Psychosoc Oncol 28:589-609, 2010.

Gore SD, Gojo I, Sekeres MA, Morris L, Devetten M, Jamieson K, Redner RL, Arceci R, Owoeye I, Dauses T, Schachter-Tokarz E, Gallagher RE. Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia. J Clin Oncol 28:1047-1053, 2010. PMCID: PMC2834430

Goyal K, Einstein D, Yao M, Kunos C, Barton F, Singh D, Siegel C, Stulberg J, Sanabria J. Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results. HPB Surg 2010:309780, 2010. PMCID: PMC2905697

Grant PM, Komarow L, Andersen J, Sereti I, Pahwa S, Lederman MM, Eron J, Sanne I, Powderly W, Hogg E, Suckow C, Zolopa A. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One 5:e11416, 2010. PMCID: PMC2895658

Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, Jenkins R, Le Marchand L, Casey G, Haile R, Hopper J, Jenkins M, Young J, Buchanan D, Gallinger S, Adams M, Lewis S, Willis J, Elston R, Markowitz SD, Wiesner GL. Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Res 70:5409-5418, 2010. PMCID: PMC2896448

Gray JD, Nakouzi G, Slowinska-Castaldo B, Dazard JE, Rao JS, Nadeau JH, Ross ME. Functional interactions between the LRP6 WNT co-receptor and folate supplementation. Hum Mol Genet 19:4560-4572, 2010. PMCID: PMC2972692

Greber B, Wu G, Bernemann C, Joo JY, Han DW, Ko K, Tapia N, Sabour D, Sterneckert J, Tesar P, Schler HR. Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell 6:215-226, 2010.

Greenwood CM, Sun S, Veenstra J, Hamel N, Niell B, Gruber S, Foulkes WD. How old is this mutation? - a study of three Ashkenazi Jewish founder mutations. BMC Genet 11:39, 2010. PMCID: PMC2889843

Grommes C, Conway DS, Alshekhlee A, Barnholtz-Sloan JS. Inverse association of PPAR? agonists use and high grade glioma development. J Neurooncol 100:233-239, 2010.

Gruber JD, Paliwal A, Krishnaswamy V, Ghadyani H, Jermyn M, O'Hara JA, Davis SC, Kerley-Hamilton JS, Shworak NW, Maytin EV, Hasan T, Pogue BW. System development for high frequency ultrasound-guided fluorescence quantification of skin layers. J Biomed Opt 15:026028, 2010. PMCID: PMC2866260

Gruver AM, Hansel DE, Luthringer DJ, Maclennan GT. Congenital mesoblastic nephroma. J Urol 183:1188-1189, 2010.

Gu L, Zhang GF, Kombu RS, Allen F, Kutz G, Brewer WU, Roe CR, Brunengraber H. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production and liver acyl-CoA profile. Am J Physiol Endocrinol Metab 298:E362-E371, 2010. PMCID: PMC2822475

Gulen MF, Kang Z, Bulek K, Youzhong W, Kim TW, Chen Y, Altuntas CZ, Bak-Jenson K, McGeachy MJ, Do JS, Xiao H, Delgoffe GM, Min B, Powell JD, Tuohy VK, Cua DJ, Li X. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32:54-66, 2010. PMCID: PMC3015141

Gupta A, Roy S, Lazar AJ, Wang WL, McAuliffe JC, Reynoso D, McMahon J, Taguchi T, Floris G, Debiec-Rychter M, Schoffski P, Trent JA, Debnath J, Rubin BP. Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proc Natl Acad Sci U S A 107:14333-14338, 2010. PMCID: PMC2922542

Gupta S, Bavro VN, D'Mello R, Tucker SJ, Vnien-Bryan C, Chance MR. Conformational changes during the gating of a potassium channel revealed by structural mass spectrometry. Structure 18:839-846, 2010.

Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, Waller E, Dipersio JF, Bunjes DW, Weisdorf DJ. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood 116:1839-1848, 2010.

Hade EM, Murray DM, Pennell ML, Rhoda D, Paskett ED, Champion VL, Crabtree BF, Dietrich A, Dignan MB, Farmer M, Fenton JJ, Flocke S, Hiatt RA, Hudson SV, Mitchell M, Monahan P, Shariff-Marco S, Slone SL, Stange K, Stewart SL, Strickland PA. Intraclass correlation estimates for cancer screening outcomes: estimates and applications in the design of group-randomized cancer screening studies. J Natl Cancer Inst Monogr 2010:97-103, 2010. PMCID: PMC2924625

Halat S, Eble JN, Grignon DJ, Lopez-Beltran A, Montironi R, Tan PH, Wang M, Zhang S, Maclennan GT, Cheng L. Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol 23:931-936, 2010.

Hall MJ, Egleston B, Miller SM, Buzaglo JS, Millard J, Ridgway C, Damjanov N, Sprandio JD, Meropol NJ. Barriers to participation in cancer prevention clinical trials. Acta Oncol 49:757-766, 2010. PMCID: PMC2901417

Hamik A, Jain MK. PLDing a case for angiogenesis. Blood 116:1194-1196, 2010.

Hamik A, Jain MK. Shear stress: devil's in the details. Blood 116:2625-2626, 2010.

Hamilton T, Novotny M, Pavicic PJ Jr, Herjan T, Hartupee J, Sun D, Zhao C, Datta S. Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression. Cytokine 52:116-122, 2010. PMCID: PMC2919655

Han L, Zheng S, Sun S, Huang TH, Zhao Z. Genome-wide DNA methylation profiling in 40 breast cancer cell lines. Advanced Intelligent Computing Theories and Applications. Lect Notes Comput Sci 6215:277-284, 2010.

Han Y, Kuang SZ, Gomer A, Ramirez-Bergeron DL. Hypoxia influences the vascular expansion and differentiation of embryonic stem cell cultures through the temporal expression of VEGF- receptors in an ARNT-dependent manner. Stem Cells 28:799-809, 2010. PMCID: PMC2989499

Hansel DE, Platt E, Orloff M, Harwalker J, Sethu S, Hicks JL, De Marzo A, Steinle RE, Hsi ED, Theodorescu D, Ching CB, Eng C. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma. Am J Pathol 176:3062-3072, 2010. PMCID: PMC2877865

Hansel DE. Bitter melon: adding zing to breast cancer treatment. Sci Transl Med 2:23ec43, 2010.

Hansel DE. Bone metastases in prostate cancer: finding the Achilles' heel. Sci Transl Med 2:14ec5, 2010.

Hansel DE. Does cancer know which way is up? Sci Transl Med 2:26ec56, 2010.

Hansel DE. Micrometastases + math = model of breast cancer dormancy. Sci Transl Med 2:35ec92, 2010.

Hansel DE. Ovarian cancer going viral. Sci Transl Med 2:17ec18, 2010.

Hansel DE. Predicting recurrent clostridium difficile infection. Sci Transl Med 2:59ec183, 2010.

Hansel DE. The haze clears: second-hand tobacco smoke a risk for bladder cancer. Sci Transl Med 2:62ec195, 2010.

Hansel DE. The new dish on fish. Sci Transl Med 2:56ec172, 2010.

Hansel DE. To vaccinate or not: parents decide. Sci Transl Med 2:53ec160, 2010.

Harding CV, Canaday D, Ramachandra L. Choosing and preparing antigen-presenting cells. Curr Protoc Immunol 16:16.1, 2010.

Harding CV, Ramachandra L. Presenting exogenous antigen to T cells. Curr Protoc Immunol 16:16.2, 2010.

Hardy SJ, Nowacki AS, Bertin M, Weil RJ. Absence of an association between glucose levels and surgical site infections in patients undergoing craniotomies for brain tumors. J Neurosurg 113:161-166, 2010.

Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, Lemaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 16:395-1402, 2010. PMCID: PMC2833344

Harr MW, Caimi PF, McColl KS, Zhong F, Patel SN, Barr PM, Distelhorst CW. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia. Cell Death Differ 17:1381-1391, 2010.

Harr MW, Distelhorst CW. Apoptosis and autophagy: decoding calcium signals that mediate life or death. Cold Spring Harb Perspect Biol 2:a005579, 2010.

Harr MW, McColl KS, Zhong F, Molitoris JK, Distelhorst CW. Glucocorticoids downregulate Fyn and inhibit IP(3)-mediated calcium signaling to promote autophagy in T lymphocytes. Autophagy 6:912-921, 2010.

Hashemi-Sadraei N, Peereboom DM. Chemotherapy in newly diagnosed primary central nervous system lymphoma. Ther Adv Med Oncol 2:273-292, 2010.

Hazen RA, Eder M, Drotar D, Zyzanski S, Reynolds AE, Reynolds CP, Kodish E, Noll RB; on behalf of the Multi-Site Intervention Study to Improve Consent Research Team. A feasibility trial of a video intervention to improve informed consent for parents of children with leukemia. Pediatr Blood Cancer 55:113-118, 2010. PMCID: PMC2874099

He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, Diaz Jr LA, Kinzler KW, Vogelstein B, Papadopoulos N. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464:610-614, 2010.

Heald B, Mester J, Rybicki L, Orloff MS, Burke CA, Eng C. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 139:1927-1933, 2010.

Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB, Rich JN. Hypoxia inducible factors in cancer stem cells. Br J Cancer 102:789-795, 2010. PMCID: PMC2833246

Heinberg LJ, Kutchman EM, Berger NA, Lawhun SA, Cuttler L, Seabrook RC, Horwitz SM. Parent involvement is associated with early success in obesity treatment. Clin Pediatr (Phila) 49:457-465, 2010.

Hemberger M, Udayashankar R, Tesar P, Moore H, Burton GJ. ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta. Hum Mol Genet 19:2456-2467, 2010.

Hernandez A, Madina BR, Ro K, Wohlschlegel JA, Willard B, Kinter MT, Cruz-Reyes J. REH2 RNA helicase in kinetoplastid mitochondria: ribonucleoprotein complexes and essential motifs for unwinding and guide RNA (gRNA) binding. J Biol Chem 285:1220-1228, 2010. PMCID: PMC2801250

Hickman RL Jr, Daly BJ, Douglas SL, Clochesy JM. Informational coping style and depressive symptoms in family decision makers. Am J Crit Care 19:410-420, 2010.

Hicks DG, Janarthanan BR, Vardarajan R, Kulkarni SA, Khoury T, Dim D, Budd GT, Yoder BJ, Tubbs R, Schreeder MT, Estopinal NC, Beck RA, Wang Y, Ring BZ, Seitz RS, Ross DT. The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence. BMC Cancer 10:108, 2010. PMCID: PMC2859753

Hill BT, Bolwell BJ, Rybicki L, Dean R, Kalaycio M, Pohlman B, Tench S, Sobecks R, Andresen S, Copelan E. Nonmyeloablative second transplants are associated with lower non- relapse mortality and superior survival than myeloablative second transplants. Biol Blood Marrow Transplant 16:1738-1746, 2010.

Hill BT, Copelan EA. Acute myeloid leukemia: when to transplant in first complete remission. Curr Hematol Malig Rep 5:101-108, 2010.

Hirsch BM, Gallo CA, Du Z, Wang Z, Zheng W. Discovery of potent, proteolytically stable, and cell permeable human sirtuin peptidomimetic inhibitors containing Ne-thioacetyl-lysine. Med Chem Comm 1:233-238, 2010.

Hitomi M, Stacey DW. The checkpoint kinase ATM protects against stress-induced elevation of cyclin D1 and potential cell death in neurons. Cytometry A 77:524-533, 2010.

Hjelmeland AB, Wu Q, Wickman S, Eyler C, Heddleston J, Shi Q, Lathia JD, Macswords J, Lee J, McLendon RE, Rich JN. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol 8:e1000319, 2010. PMCID: PMC2826371

Hofmann ER, Nallar SC, Lin L, D'Cunha J, Lindner DJ, Weihua X, Kalvakolanu DV. Identification and characterization of GRIM-1, a cell-death-associated gene product. J Cell Sci 123:2781-2791, 2010. PMCID: PMC2915880

Hong V, Steinmetz NF, Manchester M, Finn MG. Labeling live cells by copper-catalyzed alkyne--azide click chemistry. Bioconjug Chem 21:1912-1916, 2010.

Howard MT, Bejanyan N, Maciejewski JP, Hsi ED. T/NK large granular lymphocyte leukemia and coexisting monoclonal B-cell lymphocytosis-like proliferations. An unrecognized and frequent association. Am J Clin Pathol 133:936-941, 2010.

Hsu JJ, Kamath-Loeb AS, Glick E, Wallden B, Swisshelm K, Rubin BP, Loeb LA. Werner syndrome gene variants in human sarcomas. Mol Carcinog 49:166-174, 2010. PMCID: PMC2813347

Hu Y, Lu X, Luo G. Effect of Recql5 deficiency on the intestinal tumor susceptibility of Apc(min) mice. World J Gastroenterol 16:1482-1486, 2010. PMCID: PMC2846253

Hu Z, Negrotto S, Gu X, Mahfouz R, Ng KP, Ebrahem Q, Copelan E, Singh H, Maciejewski JP, Saunthararajah Y. Decitabine maintains hematopoietic precursor self-renewal by preventing repression of stem cell genes by a differentiation-inducing stimulus. Mol Cancer Ther 9:1536-1543, 2010. PMCID: PMC2884053

Huang D, Ding Y, Zhou M, Rini BI, Petillo D, Qian CN, Kahnoski R, Futreal PA, Furge KA, Teh BT. Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma. Cancer Res 70:1063-1071, 2010.

Huang ST, Good M, Zauszniewski JA. The effectiveness of music in relieving pain in cancer patients: a randomized controlled trial. Int J Nurs Stud 47:1354-1362, 2010.

Huang Z, Cheng L, Guryanova OA, Wu Q, Bao S. Cancer stem cells in glioblastoma-molecular signaling and therapeutic targeting. Protein Cell 1:638-655, 2010.

Hudson TJ, Anderson W, Artez A, Barker ADWiesner GL.412 collaborators (International Cancer Genome Consortium). International network of cancer genome projects. Nature 464:993-998, 2010. PMCID: PMC2902243

Huh J, Tiu RV, Gondek LP, O'Keefe CL, Jasek M, Makishima H, Jankowska AM, Jiang Y, Verma A, Theil KS, McDevitt MA, Maciejewski JP. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes Chromosomes Cancer 49:390-399, 2010.

Hurskainen TL, Apte SS. In situ hybridization for metalloproteinases and their inhibitors. Methods Mol Biol 622:195-209, 2010.

Hursting SD, Berger NA. Energy balance, host-related factors, and cancer progression. J Clin Oncol 28:4058-4065, 2010. PMCID: PMC2982796

Hussein M, Berenson JR, Niesvizky R, Munshi N, Matous J, Sobecks R, Harrop K, Drachman JG, Whiting N. A phase 1 multidose study of dacetuzumab (SGN-40; humanized anti-CD40 mAb) in patients with multiple myeloma. Haematologica 95:845-848, 2010. PMCID: PMC2864394

Hussong JW, Arber DA, Bradley KT, Brown MS, Chang CC, de Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Lill M, McClure SP, Medeiros LJ, Perkins SL; Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with non-Hodgkin lymphoma/lymphoid neoplasms. Arch Pathol Lab Med 134:e40-e47, 2010.

Hutson TE, Bellmunt J, Porta C, Szczylik C, Staehler M, Nadel A, Anderson S, Bukowski R, Eisen T, Escudier B; Sorafenib TARGET Clinical Trial Group. Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase III TARGET. Eur J Cancer 46:2432-2440, 2010.

Im E, Rhee SH, Park YS, Fiocchi C, Tach Y, Pothoulakis C. Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis. Gastroenterology 138:2457-2467, 2467.e1-e5, 2010. PMCID: PMC2883634

Ingram DG, Kattan MW. Risk grouping versus risk continuum in patients with clinically localized prostate cancer: a taxometric test. J Urol 184:1937-1941, 2010.

Ishii D, Schenk AD, Baba S, Fairchild RL. Role of TNFalpha in early chemokine production and leukocyte infiltration into heart allografts. Am J Transplant 10:59-68, 2010. PMCID: PMC2806937

Ito JI, Kriengkauykiat J, Dadwal SS, Arfons LM, Lazarus HM. Approaches to the early treatment of invasive fungal infection. Leuk Lymphoma 51:1623-1631, 2010.

Jan CR, Crabtree BF, Palmer RF, Ferrer RL, Nutting PA, Miller WL, Stewart EE, Wood R, Davila M, Stange KC. Methods for evaluating practice change toward a patient-centered medical home. Ann Fam Med 8 Suppl 1:S9-20, 2010. PMCID: PMC2885721

Jan CR, Ferrer RL, Miller WL, Palmer RF, Wood R, Davila M, Stewart EE, Crabtree BF, Nutting PA, Stange KC. Patient outcomes at 26 months in the patient-centered medical home National Demonstration Project. Ann Fam Med 8 Suppl 1:S57-67, 2010. PMCID: PMC2885729

Jagannathan R, Kaveti S, Desnoyer RW, Willard B, Kinter M, Karnik SS. AT1 receptor induced alterations in histone H2A reveal novel insights into GPCR control of chromatin remodeling. PLoS One 5:e12552, 2010. PMCID: PMC2933232

Jani TS, Devecchio J, Mazumdar T, Agyeman A, Houghton JA. Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines (cc) and is synergistic in combination with TRAIL or oxaliplatin. J Biol Chem 285:19162-19172, 2010. PMCID: PMC2885195

Jankowsky E, Putnam A. Duplex unwinding with DEAD-Box proteins. Methods Mol Biol 587:245-264, 2010.

Jasek M, Gondek LP, Bejanyan N, Tiu R, Huh J, Theil KS, O'Keefe C, McDevitt MA, Maciejewski JP. TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p. Leukemia 24:216-219, 2010. PMCID: PMC2806506

Javed A, Canales BK, Maclennan GT. Bladder amyloidosis. J Urol 183:2388-2389, 2010.

Jenkins MW, Peterson L, Gu S, Gargesha M, Wilson DL, Watanabe M, Rollins AM. Measuring hemodynamics in the developing heart tube with four-dimensional gated Doppler optical coherence tomography. J Biomed Opt 15:066022, 2010.

Jin G, Kawsar HI, Hirsch SA, Zeng C, Jia X, Feng Z, Ghosh SK, Zheng QY, Zhou A, McIntyre TM, Weinberg A. An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One 5:e10993, 2010. PMCID: PMC2882331

Jin G. Using biomarkers to detect oral cancer holds potential for saving lives when the cancer is most curable. Biomark Med 4:835-838, 2010.

Jinno S, Gripshover BM, Lemonovich TL, Anderson JM, Jacobs MR. Histoplasma capsulatum prosthetic valve endocarditis with negative fungal blood cultures and negative histoplasma antigen assay in an immunocompetent patient. J Clin Microbiol 48:4664-4666, 2010.

Johnson DH, Narayan S, Flask CA, Wilson DL. Improved fat-water reconstruction algorithm with graphics hardware acceleration. J Magn Reson Imaging 31:457-465, 2010. PMCID: PMC2866013

Johnson E, Seachrist DD, Deleon-Rodriguez CM, Lozada KL, Miedler J, Abdul-Karim FW, Keri RA. HER2/ErbB2-induced breast cancer cell migration and invasion requires p120 catenin activation of Rac1 and Cdc42. J Biol Chem 285:29491-29501, 2010. PMCID: PMC2937981

Joshi N, Bissada NF, Bodner D, Maclennan GT, Narendran S, Jurevic R, Skillicorn R. Association between periodontal disease and prostate specific antigen levels in chronic prostatitis patients. J Periodontol 81:864-869, 2010.

Kahana E, Kahana B, Wykle M. "Care-getting": a conceptual model of marshalling support near the end of life. Curr Aging Sci 3:71-78, 2010.

Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP, Gupta V, Maharaj D, Marks DI, Pavletic SZ, Horowitz MM, Arora M. Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. Biol Blood Marrow Transplant 16:543-547, 2010. PMCID: PMC2839005

Kannan-Thulasiraman P, Seachrist DD, Mahabeleshwar GH, Jain MK, Noy N. Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth. J Biol Chem 285:19106-19115, 2010. PMCID: PMC2885189

Kantarjian H, Fenaux P, Sekeres MA, Becker PS, Boruchov A, Bowen D, Hellstrom-Lindberg E, Larson RA, Lyons RM, Muus P, Shammo J, Siegel R, Hu K, Franklin J, Berger DP. Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia. J Clin Oncol 28:437-444, 2010.

Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411-422, 2010.

Kanwal R, Gupta S. Epigenetics and cancer. J Appl Physiol 109:598-605, 2010. PMCID: PMC2928601

Kaouk JH, Goel RK, White MA, White WM, Autorino R, Haber GP, Campbell SC. Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection: initial experience and 2-year follow-up. Urology 76:857-861, 2010.

Kaplan D, Meyerson HJ, Li X, Drasny C, Liu F, Costaldi M, Barr P, Lazarus HM. Correlation between ZAP-70, phospho-ZAP-70, and phospho-Syk expression in leukemic cells from patients with CLL. Cytometry B Clin Cytom 78:115-122, 2010.

Karunamuni G, Yang K, Doughman YQ, Wikenheiser J, Bader D, Barnett J, Austin A, Parsons-Wingerter P, Watanabe M. Expression of lymphatic markers furing avian and mouse cardiogenesis. Anat Rec (Hoboken) 293:259-270, 2010.

Kato I, Land S, Majumdar AP, Barnholtz-Sloan J, Severson RK. Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer. Cancer Epidemiol 34:291-297, 2010. PMCID: PMC2905870

Kato I, Majumdar AP, Land SJ, Barnholtz-Sloan JS, Severson RK. Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer 127:942-951, 2010. PMCID: PMC2891322

Kattan MW, Jones JS. The ultimate prostate cancer biopsy decision support tool. Eur Urol 57:9-11, 2010.

Kattan MW, Marasco J. What is a real nomogram? Semin Oncol 37:23-26, 2010.

Kattan MW, Schrder FH. What patients newly diagnosed with clinically localized prostate cancer need to see: an editorial dialogue. Eur Urol 58:258-260, 2010.

Kattan MW. Classification and regression trees versus nomograms: a bone scan positivity example. Eur Urol 57:559-560, 2010.

Kattan MW. Comparing prediction tools. Eur Urol 57:569-570, 2010.

Kattan MW. Editorial comment [Comparison of the UCLA integrated staging system and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma]. Urology 75:1371-1372, 2010.

Kattan MW. Evaluating a marker's contribution to a nomogram: the GEMCaP example. Clin Cancer Res 16:1-3, 2010.

Kattan MW. The many uses of cancer prediction tools. Semin Oncol 37:20-22, 2010.

Katz MS, Efstathiou JA, D'Amico AV, Kattan MW, Sanda MG, Nguyen PL, Smith MR, Carroll PR, Zietman AL. The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer. BJU Int 105:1417-1422, 2010.

Kawsar HI, Ghosh SK, Hirsch SA, Koon HB, Weinberg A, Jin G. Expression of human beta-defensin-2 I n intratumoral vascular endothelium and

Kerr BA, Byzova TV. alphaB-crystallin: a novel VEGF chaperone. Blood 115:3181-3183, 2010.

Kerr BA, Miocinovic R, Smith AK, Klein EA, Byzova TV. Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model. Neoplasia 12:388-396, 2010. PMCID: PMC2864476

Kerstetter AE, Miller RH. Research highlights. Makes you think: rescue of radiation-induced cognitive impairments with human embryonic stem cells. Regen Med 5:175-176, 2010.

Kessel D, Oleinick NL. Photodynamic therapy and cell death pathways. Methods Mol Biol 635:35-46, 2010.

Khan G, Golshayan A, Elson P, Wood L, Garcia J, Bukowski R, Rini B. Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency. Ann Oncol 21:1618-1622, 2010.

Khoriaty R, Hussein MA, Faiman B, Kelly M, Kalaycio M, Baz R. Prediction of response and progression in multiple myeloma with serum free light chains assay: corroboration of the serum free light chain response definitions. Clin Lymphoma Myeloma Leuk 10:E10-E13, 2010.

Khurana K, Gilligan TD, Stephenson AJ. Management of poor-prognosis testicular germ cell tumors. Indian J Urol 26:108-114, 2010. PMCID: PMC2878420

Khutornenko AA, Roudko VV, Chernyak BV, Vartapetian AB, Chumakov PM, Evstafieva AG. Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway. Proc Natl Acad Sci U S A 107:12828-12833, 2010. PMCID: PMC2919937

Kim EJ, Boehm CA, Mata A, Fleischman AJ, Muschler GF, Roy S. Post microtextures accelerate cell proliferation and osteogenesis. Acta Biomater 6:160-169, 2010.

Kim J, Fujioka H, Oleinick NL, Anderson VE. Photosensitization of intact heart mitochondria by the phthalocyanine Pc 4: correlation of structural and functional deficits with cytochrome c release. Free Radic Biol Med 49:726-732, 2010. PMCID: PMC2921926

Kim J, Rodriguez ME, Oleinick NL, Anderson VE. Photo-oxidation of cardiolipin and cytochrome c with bilayer-embedded Pc 4. Free Radic Biol Med 49:718-725, 2010. PMCID: PMC2921921

Kim JJ, Rini BI, Hansel DE. Von Hippel Lindau syndrome. Adv Exp Med Biol 685:228-249, 2010.

Kim R, El-Gazzaz G, Tan A, Elson P, Byrne M, Chang YD, Aucejo F. Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation. Oncology 79:62-66, 2010.

Kim R, Tsao R, Tan A, Byrne M, Almhanna K, Lazaryan A, Elson P, Pelley RJ. A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: Outcome and prognostic indicators. J Gastrointest Surg 14:1159-1169, 2010.

Kim S, Morris NJ, Won S, Elston RC. Single-marker and two-marker association tests for unphased case-control genotype data, with a power comparison. Genet Epidemiol 34:67-77 2010. PMCID: PMC2796706

Kim S, Prout M, Ramshaw H, Lopez AF, Legros G, Min B. Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection-induced Th2 immunity can develop without basophil lymph node recruitment or IL-3. J Immunol 184:1143-1147, 2010. PMCID: PMC2849628

Kim S, Rusmevichientong A, Dong B, Remenyi R, Silverman RH, Chow SA. Fidelity of target site duplication and sequence preference during integration of xenotropic murine leukemia virus-related virus. PLoS One 5:e10255, 2010. PMCID: PMC2857682

Kim S, von Recum HA. Endothelial progenitor populations in differentiating embryonic stem cells II: drug selection and functional characterization. Tissue Eng Part A 16:1065-1074, 2010.

Kirches E, Steiner J, Schneider T, Vorwerk CK, Scherlach C, Holtkamp N, Keilhoff G, Eng C, Mawrin C. Lhermitte-Duclos disease caused by a novel germline PTEN mutation R173P in a patient presenting with psychosis. Neuropathol Appl Neurobiol 36:86-89, 2010.

Kirkova J, Aktas A, Walsh D, Rybicki L, Davis MP. Consistency of symptom clusters in advanced cancer. Am J Hosp Palliat Care 27:342-346, 2010.

Kirkova J, Walsh D, Aktas A, Davis MP. Cancer symptom clusters: old concept but new data. Am J Hosp Palliat Care 27:282-288, 2010.

Kirkova J, Walsh D, Rybicki L, Davis MP, Aktas A, Jin T, Homsi J. Symptom severity and distress in advanced cancer. Palliat Med 24:330-339, 2010.

Kiselar JG, Chance MR. Future directions of structural mass spectrometry using hydroxyl radical footprinting. J Mass Spectrom 45:1373-1382, 2010.

Kishida T, Yao M, Uemura H, Ohlmann C, Tomita Y, Bukowski RM, Naito S. Molecular genetic events associated with renal cell carninoma and its implication to treatment by molecular target therapy. Int J Urol 17:198-205, 2010.

Klenotic PA, Huang P, Palomo J, Kaur B, Van Meir EG, Vogelbaum MA, Febbraio M, Gladson CL, Silverstein RL. Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin. Am J Pathol 176:2039-2050, 2010. PMCID: PMC2843491

Knight PT, Kirk JT, Anderson JM, Mather PT. In vivo kinetic degradation analysis and biocompatibility of aliphatic polyester polyurethanes. J Biomed Mater Res A 94:333-343, 2010.

Ko AB, Lavertu P, Rezaee RP. Double bilobed radial forearm free flap for anterior tongue and floor-of-mouth reconstruction. Ear Nose Throat J 89:177-179, 2010.

Ko IK, Kim BG, Awadallah A, Mikulan J, Lin P, Letterio JJ, Dennis JE. Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther 18:1365-1372, 2010. PMCID: PMC2911249

Ko JS, Rayman P, Ireland J, Swaidani S, Li G, Bunting KD, Rini B, Finke JH, Cohen PA. Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib Is compartmentally constrained. Cancer Res 70:3526-3536, 2010.

Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, Liu XS, Aravind L, Agarwal S, Maciejewski JP, Rao A. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468:839-843, 2010. PMCID: PMC3003755

Koo BH, Apte SS. Cell-surface processing of the metalloprotease pro-ADAMTS9 is influenced by the chaperone GRP94/GP96. J Biol Chem 285:197-205, 2010. PMCID: PMC2804166

Koo BH, Coe DM, Dixon LJ, Somerville RP, Nelson CM, Wang LW, Young ME, Lindner DJ, Apte SS. ADAMTS9 Is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells. Am J Pathol 176:1494-1504, 2010. PMCID: PMC2832168

Koroukian SM, Xu F, Bakaki PM, Diaz-Insua M, Towe TP, Owusu C. Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer. J Gerontol A Biol Sci Med Sci 65:322-329, 2010. PMCID: PMC2904594

Kouzminova N, Lu T, Lin AY, Purnak T, Ozaslan E, Efe C, Batistatou A, Charalabopoulos A, Charalabopoulos K, Markowitz SD, Bertagnolli MM. Molecular basis of colorectal cancer. N Engl J Med 362:1245-1247, 2010.

Koyfman SA, Tendulkar RD, Chao ST, Vogelbaum MA, Barnett GH, Angelov L, Weil RJ, Neyman G, Reddy CA, Suh JH. Stereotactic radiosurgery for single brainstem metastases: the Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 78:409-414, 2010.

Koyutrk M. Algorithmic and analytical methods in network biology. Wiley Interdiscip Rev Syst Biol Med 2:277-292, 2010.

Krebs MD, Salter E, Chen E, Sutter KA, Alsberg E. Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis. J Biomed Mater Res A 92:1131-1138, 2010.

Krishnamurthi G, Wang CY, Steyer G, Wilson DL. Removal of subsurface fluorescence in cryo-imaging using deconvolution. Opt Express 18:22324-22338, 2010.

Krupka TM, Solorio L, Wilson RE, Wu H, Azar N, Exner AA. Formulation and characterization of echogenic lipid-pluronic nanobubbles. Mol Pharm 7:49-59, 2010.

Kuang Y, Salem N, Corn DJ, Erokwu B, Tian H, Wang F, Lee Z. Transport and metabolism of radiolabeled choline in hepatocellular carcinoma. Mol Pharm 7:2077-2092, 2010. PMCID: PMC2992798

Kubicek GJ, Champ C, Fogh S, Wang F, Reddy E, Intenzo C, Dusing RW, Machtay M. FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol 2:19, 2010. PMCID: PMC2915991

Kudahetti SC, Fisher G, Ambroisine L, Prowse D, Kattan MW, Foster CS, Mller H, Oliver T, Fletcher A, Cooper C, Reuter V, Scardino P, Cuzick J, Berney DM; Transatlantic Prostate Group. Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. Pathology 42:519-523, 2010.

Kulkarni S, Reddy KB, Esteva FJ, Moore HC, Budd GT, Tubbs RR. Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer. Oncogene 29:1339-1350, 2010

Kumon RE, Pollack MJ, Faulx AL, Olowe K, Farooq FT, Chen VK, Zhou Y, Wong RC, Isenberg GA, Sivak MV, Chak A, Deng CX. In vivo characterization of pancreatic and lymph node tissue by using EUS spectrum analysis: a validation study. Gastrointest Endosc 71:53-63, 2010. PMCID: PMC2900783

Kundu S, Fan K, Cao M, Lindner DJ, Tuthill R, Liu L, Gerson S, Borden E, Yi T. Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics. Mol Cancer Ther 9:2287-2296, 2010. PMCID: PMC2942023

Kundu S, Fan K, Cao M, Lindner DJ, Zhao ZJ, Borden E, Yi T. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. J Immunol 184:6529-6536, 2010.

Kunos C, Ali S, Abdul-Karim FW, Stehman FB, Waggoner S. Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study. Am J Obstet Gynecol 203:351.e1-351.e8, 2010. PMCID: PMC2947558

Kunos C. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol 115:190, 2010.

Kunos CA, Radivoyevitch T, Pink J, Chiu SM, Stefan T, Jacobberger J, Kinsella TJ. Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers. Radiat Res 174:574-581, 2010.

Kunos CA, Waggoner S, von Gruenigen V, Eldermire E, Pink J, Dowlati A, Kinsella TJ. Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer. Clin Cancer Res 16:1298-1306, 2010. PMCID: PMC2822897

Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, Puri RK; PRECISE Study Group. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 12:871-881, 2010. PMCID: PMC2940677

Kurokawa J, Arai S, Nakashima K, Nagano H, Nishijima A, Miyata K, Ose R, Mori M, Kubota N, Kadowaki T, Oike Y, Koga H, Febbraio M, Iwanaga T, Miyazaki T. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab 11:479-492, 2010.

Ladenson PW, McCarren M, Morkin E, Edson RG, Shih MC, Warren SR, Barnhill JG, Churby L, Thai H, O'Brien T, Anand I, Warner A, Hattler B, Dunlap M, Erikson J, Goldman S. Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. J Clin Endocrinol Metab 95:1349-1354, 2010.

Lalonde MS, Arts EJ. DNA suspension arrays: silencing discrete artifacts for high-sensitivity applications. PLoS One 5:e15476, 2010. PMCID: PMC2975679

Lam M, Lee Y, Deng M, Hsia AH, Morrissey KA, Yan C, Azzizudin K, Oleinick NL, McCormick TS, Cooper KD, Baron ED. Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome. Adv Hematol 2010:896161, 2010.

Lane BR, Abouassaly R, Gao T, Weight CJ, Hernandez AV, Larson BT, Kaouk JH, Gill IS, Campbell SC. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer 116:3119-3126, 2010.

Lane BR, Campbell SC. Editorial comment [Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery]. Urology 75:281, 2010.

Lane BR, Campbell SC. Editorial comment [Ureteral fibrin sealant injection of the distal ureter during laparoscopic nephroureterectomya novel and simple modification of the pluck technique]. Urology 75:193, 2010.

Lane BR, Campbell SC. Is radical nephrectomy overused in elderly kidney cancer patients? Aging Health 6:587-589, 2010.

Lane BR, Demirjian S, Weight CJ, Larson BT, Poggio ED, Campbell SC. Performance of the chronic kidney disease-epidemiology study equations for estimating glomerular filtration rate before and after nephrectomy. J Urol 183:896-901, 2010.

Lane BR, Fergany AF, Weight CJ, Campbell SC. Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy. J Urol 184:1286-1290, 2010.

Lane BR, Smith AK, Larson BT, Gong MC, Campbell SC, Raghavan D, Dreicer R, Hansel DE, Stephenson AJ. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116:2967-2973, 2010.

Larusch GA, Mahdi F, Shariat-Madar Z, Adams G, Sitrin RG, Zhang WM, McCrae KR, Schmaier AH. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis. Blood 115:5111-5120, 2010. PMCID: PMC2890145

Lasheen W, Walsh D, Mahmoud F, Davis MP, Rivera N, Khoshknabi DS. Methylphenidate side effects in advanced cancer: a retrospective analysis. Am J Hosp Palliat Care 27:16-23, 2010.

Lasheen W, Walsh D, Mahmoud F, Sarhill N, Rivera N, Davis MP, Lagman R, LeGrand S. The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain. Palliat Med 24:9-16, 2010.

Lasheen W, Walsh D, Sarhill N, Davis M. Intermittent cancer pain: clinical importance and an updated cancer pain classification. Am J Hosp Palliat Care 27:182-186, 2010.

Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, Wu Q, Vasanji A, McLendon RE, Hjelmeland AB, Rich JN. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6:421-432, 2010. PMCID: PMC2884275

Lathia JD, Rich JN. Blood vessels in neurological development and disease: more than silent spectators. Future Neurol 5:779-781, 2010.

Lavelle D, Saunthararajah Y, Vaitkus K, Singh M, Banzon V, Phiasivongsva P, Redkar S, Kanekal S, Bearss D, Shi C, Inloes R, DeSimone J. S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis). J Transl Med 8:92, 2010. PMCID: PMC2958909

Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD, Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM, Hari PN. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Biol Blood Marrow Transplant 16:35-45, 2010. PMCID: PMC2929576

Lederman MM, Alter G, Daskalakis DC, Rodriguez B, Sieg SF, Hardy G, Cho M, Anthony D, Harding C, Weinberg A, Silverman RH, Douek DC, Margolis L, Goldstein DB, Carrington M, Goedert JJ. Determinants of protection among HIV-exposed seronegative persons: an overview. J Infect Dis 202:S333-S338, 2010.

Lee C, Jaladat Y, Mohammadi A, Sharifi A, Geisler S, Valadkhan S. Metal binding and substrate positioning by evolutionarily invariant U6 sequences in catalytically active protein-free snRNAs. RNA 16:2226-2238, 2010. PMCID: PMC2957061

Lee EL, von Recum HA. Cell culture platform with mechanical conditioning and nondamaging cellular detachment. J Biomed Mater Res A 93:411-418, 2010.

Lee I, Berdis AJ. Non-natural nucleotides as probes for the mechanism and fidelity of DNA polymerases. Biochim Biophys Acta 1804:1064-1080, 2010.

Lee MC, Dong F, Stephenson AJ, Jones JS, Magi-Galluzzi C, Klein EA. The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy. Eur Urol 58:90-95, 2010.

Lee MC, Moussa AS, Yu C, Kattan MW, Magi-Galluzzi C, Jones JS. Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer. J Urol 184:1958-1962, 2010.

Lee MW, Chanda D, Yang J, Oh H, Kim SS, Yoon YS, Hong S, Park KG, Lee IK, Choi CS, Hanson RW, Choi HS, Koo SH. Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. Cell Metab 11:331-339, 2010.

Lee RG, Vecchiotti MA, Heaphy J, Panneerselvam A, Schluchter MD, Oleinick NL, Lavertu P, Alagramam KN, Arnold JE, Sprecher RC. Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft system. Laryngoscope 120:618-624, 2010.

Lee S, Antony L, Hartmann R, Knaus KJ, Surewicz K, Surewicz WK, Yee VC. Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO J 29:251-262, 2010. PMCID: PMC2808380

Lee WT, Rizzi M, Scharpf J, Lorenz RR, Saxton JP, Adelstein DJ, Esclamado RM. Impact of preepiglottic space tumor involvement on concurrent chemoradiation therapy. Am J Otolaryngol 31:185-188, 2010.

Lemke AA, Trinidad SB, Edwards KL, Starks H, Wiesner GL, Boughman J, Burke W, Dressler L, Freeman W, Gerson N, Juengst E, Lewis S, Marshall P, O'Rourke PP, Ponsaran R, Press N, Griffin MQ. GRRIP Consortium. Attitudes toward genetic research review: results from a national survey of professionals involved in human subjects protection. J Empir Res Hum Res Ethics 5:83-91, 2010. PMCID: PMC2902178

Leong HS, Steinmetz NF, Ablack A, Destito G, Zijlstra A, Stuhlmann H, Manchester M, Lewis JD. Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nat Protoc 5:1406-1417, 2010.

Li C, Xin W, Sy MS. Binding of pro-prion to filamin A: by design or an unfortunate blunder. Oncogene 29:5329-5345, 2010.

Li C, Yu S, Nakamura F, Pentikainen OT, Singh N, Yin S, Xin W, Sy MS. Pro-prion binds filamin A, facilitating its interaction with integrin beta1, and contributes to melanomagenesis. J Biol Chem 285:30328-30339, 2010. PMCID: PMC2943319

Li G, Miskimen KL, Wang Z, Xie XY, Brenzovich J, Ryan JJ, Tse W, Moriggl R, Bunting KD. STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease. Blood 115:1416-1424, 2010. PMCID: PMC2826763

Li G, Miskimen KL, Wang Z, Xie XY, Tse W, Gouilleux F, Moriggl R, Bunting KD. Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin. Leukemia 24:1397-1405, 2010. PMCID: PMC2921023

Li G, Wang Z, Miskimen KL, Zhang Y, Tse W, Bunting KD. Gab2 promotes hematopoietic stem cell maintenance and self-renewal synergistically with STAT5. PLoS One 5:e9152, 2010. PMCID: PMC2818849

Li W, Febbraio M, Reddy SP, Yu DY, Yamamoto M, Silverstein RL. CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs. J Clin Invest 120:3996-4006, 2010. PMCID: PMC2964976

Li X, Chen Y, Li J. Detecting genome-wide haplotype polymorphism by combined use of mendelian constraints and local population structure. Pac Symp Biocomput 2010:348-358, 2010.

Li X, Yin X, Li J. Efficient identification of identical-by-descent status in pedigrees with many untyped individuals. Bioinformatics 26:i191-i198, 2010. PMCID: PMC2881406

Li Z, Rich JN. Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. Curr Top Microbiol Immunol 345:21-30, 2010.

Lim JW. Linguistic and ethnic disparities in breast and cervical cancer screening and health risk behaviors among Latina and Asian American women. J Womens Health (Larchmt) 19:1097-1107, 2010.

Lin Z, Natesan V, Shi H, Dong F, Kawanami D, Mahabeleshwar GH, Atkins GB, Nayak L, Cui Y, Finigan JH, Jain MK. Kruppel-like factor 2 regulates endothelial barrier function. Arterioscler Thromb Vasc Biol 30:1952-1959, 2010.

Lin Z, Natesan V, Shi H, Hamik A, Kawanami D, Hao C, Mahabaleshwar GH, Wang W, Jin ZG, Atkins GB, Firth SM, Ritti L, Perbal B, Jain MK. A novel role of CCN3 in regulating endothelial inflammation. J Cell Commun Signal 4:141-153, 2010. PMCID: PMC2948121

Litzow MR, Othus M, Cripe LD, Gore SD, Lazarus HM, Lee SJ, Bennett JM, Paietta EM, Dewald GW, Rowe JM, Tallman MS; for the Eastern Cooperative Oncology Group Leukemia Committee. Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group. Br J Haematol 148:217-225, 2010. PMCID: PMC2809127

Litzow MR, Tarima S, Prez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 115:1850-1857, 2010. PMCID: PMC2832815

Liu L, Belkadi A, Darnall L, Hu T, Drescher C, Cotleur AC, Padovani-Claudio D, He T, Choi K, Lane TE, Miller RH, Ransohoff RM. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat Neurosci 13:319-326, 2010. PMCID: PMC2827651

Liu YC, Gray RC, Hardy GA, Kuchtey J, Abbott DW, Emancipator SN, Harding CV. CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells. J Immunol 184:3367-3376, 2010. PMCID: PMC2892962

Liu Z, Belinson SE, Li J, Yang B, Wulan N, Tresser NJ, Wang C, Mohr M, Zhang L, Zhou Y, Weng L, Wu R, Belinson JL. Diagnostic efficacy of real-time optical coherence tomography in the management of preinvasive and invasive neoplasia of the uterine cervix. Int J Gynecol Cancer 20:283-287, 2010.

Lo PH, Lung HL, Cheung AK, Apte SS, Chan KW, Kwong FM, Ko JM, Cheng Y, Law S, Srivastava G, Zabarovsky ER, Tsao SW, Tang JC, Stanbridge EJ, Lung ML. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Res 70:5567-5576, 2010. PMCID: PMC2896444

Lo SS, Sahgal A, Wang JZ, Mayr NA, Sloan A, Mendel E, Chang EL. Stereotactic body radiation therapy for spinal metastases. Discov Med 9:289-296, 2010.

Loberiza FR Jr, Lee SJ, Klein JP, Hassebroek A, Dehn JG, Frangoul HA, Hahn T, Hale G, Lazarus HM, Lemaistre CF, Maziarz RT, Rizzo JD, Majhail NS. Outcomes of hematological malignancies after unrelated donor hematopoietic-cell transplantation according to place of residence. Biol Blood Marrow Transplant 16:368-375, 2010. PMCID: PMC2822013

Lobo GP, Hessel S, Eichinger A, Noy N, Moise AR, Wyss A, Palczewski K, von Lintig J. ISX is a retinoic acid-sensitive gatekeeper that controls intestinal beta, beta-carotene absorption and vitamin A production. FASEB J 24:1656-1666, 2010. PMCID: PMC2874479

Loren DE, Azar R, Charles RJ, Dumot JA, Farooq F, Gopal DV, Jaffe DL, Shami VM, Sharma VK, Chak A; ASGE CME Programs Committee. Updated guidelines for live endoscopy demonstrations. Gastrointest Endosc 71:1105-1107, 2010.

Lorusso PM, Krishnamurthi SS, Rinehart JJ, Nabell LM, Malburg L, Chapman PB, Deprimo SE, Bentivegna S, Wilner KD, Tan W, Ricart AD. Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers. Clin Cancer Res 16:1924-1937, 2010.

Lu Q, Obuchowski N, Won S, Zhu X, Elston RC. Using the optimal robust Receiver Operating Characteristic (ROC) curve for predictive genetic tests. Biometrics 66:586-593, 2010.

Lu T, Jackson MW, Wang B, Yang M, Chance MR, Miyagi M, Gudkov AV, Stark GR. Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc Natl Acad Sci U S A 107:46-51, 2010. PMCID: PMC2806709

Lu T, Stark GR. Use of forward genetics to discover novel regulators of NF-kappaB. Cold Spring Harb Perspect Biol 2:a001966, 2010. PMCID: PMC2869522

Lu Y, Haldar S, Croce K, Wang Y, Sakuma M, Morooka T, Wang B, Jeyaraj D, Gray SJ, Simon DI, Jain MK. Kruppel-like factor 15 regulates smooth muscle response to vascular injury. Arterioscler Thromb Vasc Biol 30:1550-1552, 2010. PMCID: PMC2937185

Lu ZR. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man. Adv Drug Deliv Rev 62:246-257, 2010.

Lughezzani G, Briganti A, Karakiewicz PI, Kattan MW, Montorsi F, Shariat SF, Vickers AJ. Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. Eur Urol 58:687-700, 2010.

Luszczek W, Cheriyath V, Mekhail TM, Borden EC. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression. Mol Cancer Ther 9:2309-2321, 2010.

Lvovich V, Srikanthan S, Silverstein RL. A novel broadband impedance method for detection of cell-derived microparticles. Biosens Bioelectron 26:444-451, 2010. PMCID: PMC2946439

Ly D, Reddy CA, Klein EA, Ciezki JP. Association of body mass index with prostate cancer biochemical failure. J Urol 183:2193-2199, 2010.

Maclennan GT, Ross J, Cheng L. Cystic partially differentiated nephroblastoma. J Urol 183:1585-1586, 2010.

Madden J, Kobaly K, Minich NM, Schluchter M, Wilson-Costello D, Hack M. Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia. J Perinatol 30:103-111, 2010. PMCID: PMC2834327

Maimone S, Agrawal D, Pollack MJ, Wong RC, Willis J, Faulx AL, Isenberg GA, Chak A. Variability in measurements of pancreatic cyst size among EUS, CT, and magnetic resonance imaging modalities. Gastrointest Endosc 71:945-950, 2010.

Majhail NS, Lazarus HM, Burns LJ. A prospective study of iron-overload management in allogeneic hematopoietic-cell transplant survivors. Biol Blood Marrow Transplant 16:832-837, 2010.

Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z, Saunthararajah Y, Guinta K, Keddache MA, Putnam P, Sekeres MA, Moliterno AR, List AF, McDevitt MA, Maciejewski JP. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 24:1799-1804, 2010.

Makishima H, Rataul M, Gondek LP, Huh J, Cook JR, Theil KS, Sekeres MA, Kuczkowski E, O'Keefe C, Maciejewski JP. FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q). Leuk Res 34:447-453, 2010. PMCID: PMC2826525

Malathi K, Saito T, Crochet N, Barton DJ, Gale M Jr, Silverman RH. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 16:2108-2119, 2010. PMCID: PMC2957051

Malinin NL, Plow EF, Byzova TV. Kindlins in FERM adhesion. Blood 115:4011-4017, 2010. PMCID: PMC2875095

Mandal D, Fu P, Levine AD. REDOX regulation of IL-13 signaling in intestinal epithelial cells: Usage of alternate pathways mediates distinct gene expression patterns. Cell Signal 22:1485-1494, 2010. PMCID: PMC3006087

Mandal D, Levine AD. Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway. Inflamm Bowel Dis 16:753-764, 2010.

Manne SL, Meropol NJ, Weinberg DS, Vig H, Ali-Khan Catts Z, Manning C, Ross E, Shannon K, Chung DC. Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol 28:1366-1372, 2010. PMCID: PMC2834496

Manson GV, Ma PC. Response to pemetrexed chemotherapy in lung adenocarcinoma-bronchioloalveolar carcinoma insensitive to erlotinib. Clin Lung Cancer 11:57-60, 2010.

Marchi N, Teng Q, Ghosh C, Fan Q, Nguyen MT, Desai NK, Bawa H, Rasmussen P, Masaryk TK, Janigro D. Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity. Brain Res 1353:176-186, 2010. PMCID: PMC2933328

Marko NF, Angelov L, Toms SA, Suh JH, Chao ST, Vogelbaum MA, Barnett GH, Weil RJ. Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases. World Neurosurg 73:186-193, 2010.

Marko NF, Hamrahian AH, Weil RJ. Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors. Pituitary 13:249-255, 2010.

Marko NF, Prayson RA, Barnett GH, Weil RJ. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study. Genomics 95:16-24, 2010.

Marko NF, Weil RJ. Mathematical modeling of molecular data in translational medicine: theoretical considerations. Sci Transl Med 2:56rv4, 2010.

Marko NF, Weil RJ. Radiotherapy: neurocognitive considerations in the treatment of brain metastases. Nat Rev Clin Oncol 7:185-186, 2010.

Marko NF, Weil RJ. Surgery: remission after transsphenoidal surgery for Cushing disease. Nat Rev Endocrinol 6:307-309, 2010.

Marko NF, Weil RJ. The role of observational investigations in comparative effectiveness research. Value Health 13:989-997, 2010.

Marks DI, Wang T, Prez WS, Antin JH, Copelan E, Gale RP, George B, Gupta V, Halter J, Khoury HJ, Klumpp TR, Lazarus HM, Lewis VA, McCarthy P, Rizzieri DA, Sabloff M, Szer J, Tallman MS, Weisdorf D. The outcome of full intensity and reduced intensity conditioning matched sibling or unrelated donor (URD) transplantation in adults with Philadelphia chromosome negative acute lymphoblastic leukemia (PH- ALL) in first and second complete remission (CR1 and CR2). Blood 116:366-374, 2010. PMCID: PMC2913452

Master AM, Rodriguez ME, Kenney ME, Oleinick NL, Gupta AS. Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in vitro PDT studies. J Pharm Sci 99:2386-2398, 2010.

Matin SF, Sharma P, Gill IS, Tannenbaum C, Hobart MG, Novick AC, Finke JH. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model. J Urol 183:333-338, 2010.

Mazanec P, Klinc MA, Pitorak EF. The real story: it's in the journal. J Palliat Med 13:1386-1387, 2010.

Mazanec PM, Daly BJ, Townsend A. Hospice utilization and end-of-life care decision making of African Americans. Am J Hosp Palliat Care 27:560-566, 2010.

Mazanec SR, Daly BJ, Douglas SL, Lipson AR. The relationship between optimism and quality of life in newly diagnosed cancer patients. Cancer Nurs 33:235-243, 2010. PMCID: PMC2883261

McAchran SE, Williams DH, MacLennan GT. Renal cell carcinoma metastasis to the bladder. J Urol 184:726-727, 2010.

McClune BL, Weisdorf DJ, Pedersen TL, da Silva GT, Tallman MS, Sierra J, Dipersio J, Keating A, Gale RP, George B, Gupta V, Hahn T, Isola L, Jagasia M, Lazarus H, Marks D, Maziarz R, Waller EK, Bredeson C, Giralt S. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic dyndrome. J Clin Oncol 28:1878-1887, 2010. PMCID: PMC2860368

McCrae KR. Blind men and the APS. Blood 116:2871-2873, 2010.

Mekhail T, Masson E, Fischer BS, Gong J, Iyer R, Gan J, Pursley J, Patricia D, Williams D, Ganapathi R. Metabolism, excretion, and pharmacokinetics of oral brivanib in patients with advanced or metastatic solid tumors. Drug Metab Dispos 38:1962-1966, 2010. PMCID: PMC2967392

Merry C, Fu K, Wang J, Yeh IJ, Zhang Y. Targeting the checkpoint kinase Chk1 in cancer therapy. Cell Cycle 9:279-283, 2010.

Meyerson HJ. A practical approach to the flow cytometric detection and diagnosis of T-cell lymphoproliferative disorders. Lab Hematol 16:32-52, 2010.

Micalizzi DS, Wang CA, Farabaugh SM, Schiemann WP, Ford HL. Homeoprotein Six1 increases TGF-{beta} type I receptor and converts TGF-{beta} signaling from suppressive to supportive for tumor growth. Cancer Res 70:10371-10380, 2010.

Mickelson DM, Hatem SF, Copelan EA. Granulocyte stimulating-colony factor-associated splenic artery rupture. Leuk Lymphoma 51:335-337, 2010.

Miller RH, Bai L, Lennon DP, Caplan AI. The potential of mesenchymal stem cells for neural repair. Discov Med 9:236-242, 2010.

Miller WL, Crabtree BF, Nutting PA, Stange KC, Jan CR. Primary care practice development: a relationship-centered approach. Ann Fam Med 8 Suppl 1:S68-79, 2010. PMCID: PMC2885724

Min B. Basophils induce Th2 immunity: is this final answer? Virulence 1:399-401, 2010.

Min B. Mice that "conditionally" lack basophils, AT LAST. J Clin Invest 120:2648-2651, 2010. PMCID: PMC2912205

Min B. Th2 immunity: a step closer to completion. Immunol Cell Biol 88:235, 2010.

Minkler PE, Hoppel CL. Separation and characterization of cardiolipin molecular species by reversed-phase ion pair high-performance liquid chromatography-mass spectrometry. J Lipid Res 51:856-865, 2010. PMCID: PMC2842139

Mira H, Andreu Z, Suh H, Lie DC, Jessberger S, Consiglio A, San Emeterio J, Hortigela R, Marqus-Torrejn MA, Nakashima K, Colak D, Gtz M, Farias I, Gage FH. Signaling through BMPR-IA regulates quiescence and long-term activity of neural stem cells in the adult hippocampus. Cell Stem Cell 7:78-89, 2010.

Miwa HE, Gerken TA, Jamison O, Tabak LA. Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1. J Biol Chem 285:1208-1219, 2010. PMCID: PMC2801249

Moh CF, Siedlak SL, Tabaton M, Perry G, Castellani RJ, Smith MA. Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease. J Neurosci Methods 190:244-247, 2010. PMCID: PMC2906114

Montaez-Wiscovich ME, Shelton MD, Seachrist DD, Lozada KL, Johnson E, Miedler JD, Abdul-Karim FW, Visvader JE, Keri RA. Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells. J Pathol 222:271-281, 2010.

Moore HC, Budd GT, Sikon A, Rim A, Chellman-Jeffers M, Crowe J. Sorting through the recent controversies in breast cancer screening. Cleve Clin J Med 77:76-79, 2010.

Morgan E, Kannan-Thulasiraman P, Noy N. Involvement of fatty acid binding protein 5 and PPAR/d in prostate cancer cell growth. PPAR Res 2010:234629, 2010. PMCID: PMC2933898

Morley S, Thakur V, Danielpour D, Parker R, Arai H, Atkinson J, Barnholtz-Sloan J, Klein E, Manor D. Tocopherol transfer protein sensitizes prostate cancer cells to vitamin E. J Biol Chem 285:35578-35589, 2010. PMCID: PMC2975182

Motea EA, Berdis AJ. Terminal deoxynucleotidyl transferase: the story of a misguided DNA polymerase. Biochim Biophys Acta 1804:1151-1166, 2010. PMCID: PMC2846215

Moussa AS, Jones JS, Yu C, Fareed K, Kattan MW. Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling. BJU Int 106:1309-1314, 2010.

Moussa AS, Kattan MW, Berglund R, Yu C, Fareed K, Jones JS. A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling. BJU Int 105:352-358, 2010.

Mulligan GB, Hamrahian AH, Eray E, Faiman C, Gupta M, Pineyro MM, Makdissi A, Suh JH, Masaryk TJ, Prayson R, Weil RJ. Inferior petrosal sinus sampling: simultaneous prolactin and ACTH measurement can reduce false-negative results. Endocr Pract 16:1-20, 2010.

Mullin JE, Cooper B, Seicean S, Strunk R, Rosen C, Redline S, Kemp J, Debaun MR. Variability of pulse oximetry measurement over 1 year in children with sickle cell disease depends on initial oxygen saturation measurement. Pediatr Blood Cancer 54:1017-1019, 2010. PMCID: PMC2946164

Muramatsu H, Makishima H, Jankowska AM, Cazzolli H, O'Keefe C, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP. Mutations of E3 ubiquitin ligase Cbl family members but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. Blood 115:1969-1975, 2010. PMCID: PMC2837338

Muschler G, Raut VP, Patterson T, Wenke JC, Hollinger JO. The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Tissue Eng Part B Rev 16:123-145, 2010.

Myers J, Huang Y, Wei L, Yan Q, Huang A, Zhou L. Fucose-deficient hematopoietic stem cells have decreased self-renewal and aberrant marrow niche occupancy. Transfusion 50:2660-2669, 2010. PMCID: PMC2946970

Nabors LB, Fiveash JB, Markert JM, Kekan MS, Gillespie GY, Huang Z, Johnson MJ, Meleth S, Kuo H, Gladson CL, Fathallah-Shaykh HM. A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma. Arch Neurol 67:313-319, 2010.

Nadeau DP, Rich JN, Brietzke SE. Informed consent in pediatric surgery: do parents understand the risks? Arch Otolaryngol Head Neck Surg 136:265-269, 2010.

Nallar SC, Kalakonda S, Sun P, Ohmori Y, Hiroi M, Mori K, Lindner DJ, Kalvakolanu DV. Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for Its antitumor activity. Am J Pathol 177:896-907, 2010. PMCID: PMC2913340

Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (Hct) for acute myeloid leukemia (Aml) in adults. Biol Blood Marrow Transplant 16:1442-1450, 2010. PMCID: PMC2933950

Nedellec R, Coetzer M, Lederman MM, Offord RE, Hartley O, Mosier DE. "Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance. J Virol 84:5842-5845, 2010. PMCID: PMC2876588

Ngamruengphong S, Li F, Zhou Y, Chak A, Cooper GS, Das A. EUS and survival in patients with pancreatic cancer: a population-based study. Gastrointest Endosc 72: 78-83, 83.e1-e2, 2010.

Nguyen CT, Fu AZ, Gilligan TD, Wells BJ, Klein EA, Kattan MW, Stephenson AJ. Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis. J Clin Oncol 28:119-125, 2010.

Nguyen CT, Stephenson AJ, Kattan MW. Are nomograms needed in the management of bladder cancer? Urol Oncol 28:102-107, 2010.

Nguyen CT, Yu C, Moussa A, Kattan MW, Jones JS. Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy. J Urol 183:529-533, 2010.

Nibbe RK, Koyutrk M, Chance MR. An integrative -omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput Biol 6:e1000639, 2010. PMCID: PMC2797084

Nieman MT, LaRusch G, Fang C, Zhou Y, Schmaier AH. Oral thrombostatin FM19 inhibits prostate cancer. Thromb Haemost 104:1044-1048, 2010.

Nikfarjam M, McGee MF, Trunzo JA, Onders RP, Pearl JP, Poulose BK, Chak A, Ponsky JL, Marks JM. Transgastric natural-orifice transluminal endoscopic surgery peritoneoscopy in humans: a pilot study in efficacy and gastrotomy site selection by using a hybrid technique. Gastrointest Endosc 72:279-283, 2010.

Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457-463, 2010.

Nixon IJ, Ganly I, Hann LE, Lin O, Yu C, Brandt S, Shah JP, Shaha A, Kattan MW, Patel SG. Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features. Surgery 148:1120-1128, 2010.

Nock NL, Patrick-Melin A, Cook M, Thompson C, Kirwan JP, Li L. Higher bone density is associated with a decreased risk of colon adenomas in women. Cancer Epidemiol Biomarkers Prev 19:893, 2010.

Nour SG, Goldberg SN, Wacker FK, Rafie S, Paul S, Heidenreich JO, Rodgers M, Abdul-Karim FW, Duerk JL, Lewin JS. MR monitoring of NaCl-enhanced radiofrequency ablations: Observations on low- and high-field-strength MR images with pathologic correlation. Radiology 254:449-459, 2010.

Noy N. Between death and survival: retinoic acid in regulation of apoptosis. Annu Rev Nutr 30:201-217, 2010.

Nutting PA, Crabtree BF, Miller WL, Stewart EE, Stange KC, Jan CR. Journey to the patient-centered medical home: a qualitative analysis of the experiences of practices in the National Demonstration Project. Ann Fam Med 8 Suppl 1:S45-56, 2010. PMCID: PMC2885728

Nutting PA, Crabtree BF, Stewart EE, Miller WL, Palmer RF, Stange KC, Jan CR. Effect of facilitation on practice outcomes in the National Demonstration Project model of the patient-centered medical home. Ann Fam Med 8 Suppl 1:S33-44, 2010. PMCID: PMC2885723

Oblander SA, Brady-Kalnay SM. Distinct PTPmu-associated signaling molecules differentially regulate neurite outgrowth on E-, N-, and R-cadherin. Mol Cell Neurosci 44:78-93, 2010. PMCID: PMC2881835

Ochs-Balcom HM, Guo X, Yonebayashi T, Wiesner G, Elston RC. Program update and novel use of the DESPAIR Program to design a genome-wide linkage study using relative pairs. Hum Hered 69:45-51, 2010. PMCID: PMC2880734

O'Connor OA, Portlock C, Moskowitz C, Hamlin P, Straus D, Gerecitano J, Gonen M, Dumitrescu O, Sarasohn D, Butos J, Neylon E, Mac-Gregor Cortelli B, Blumel S, Evens AM, Zelenetz AD, Wright J, Cooper B, Winter J, Vose J. Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes. Clin Cancer Res 16:719-726, 2010.

Ogba N, Doughman YQ, Chaplin LJ, Hu Y, Gargesha M, Watanabe M, Montano MM. HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland. Oncogene 29:3639-3649, 2010. PMCID: PMC2892028

Oghlakian R, Nock C, Koubeissi M. A case of levetiracetam-induced thrombocytopenia. Epileptic Disord 12:335-337, 2010.

Ohori M, Kattan MW, Yu C, Matsumoto K, Satoh T, Ishii J, Miyakawa A, Irie A, Iwamura M, Tachibana M. Nomogram to predict seminal vesicle invasion using the status of cancer at the base of the prostate on systematic biopsy. Int J Urol 17:534-540, 2010.

O'Keefe C, McDevitt MA, Maciejewski JP. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 115:2731-2739, 2010. PMCID: PMC2854422

Omay SB, Barnett GH. Surgical navigation for meningioma surgery. J Neurooncol 99:357-364, 2010.

Orban T, Bereta G, Miyagi M, Wang B, Chance MR, Sousa MC, Palczewski K. Conformational changes in guanylate cyclase-activating protein 1 induced by Ca(2+) and N-terminal fatty acid acylation. Structure 18:116-126, 2010. PMCID: PMC2822722

Orban T, Gupta S, Palczewski K, Chance MR. Visualizing water molecules in transmembrane proteins using radiolytic labeling methods. Biochemistry 49:827-834, 2010. PMCID: PMC2819031

Pahlajani G, Raina R, Jones JS, Burdick M, Ali M, Li J, Mahadevan A, Ciezki J, Zippe C. Early intervention with phosphodiesterase-5 inhibitors after prostate brachytherapy improves subsequent erectile function. BJU Int 106:1524-1527, 2010.

Pandey M, Shukla S, Gupta S. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int J Cancer 126:2520-2533, 2010. PMCID: PMC2874465

Paner GP, Brown JG, Lapetino S, Nese N, Gupta R, Shen SS, Hansel DE, Amin MB. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens. Am J Surg Pathol 34:792-799, 2010.

Pant S, Hamadani M, Dodds AJ, Szer J, Crilley PA, Stevenson D, Phillips G, Elder P, Nivison-Smith I, Avalos BR, Penza S, Topolsky D, Sobecks R, Kalaycio M, Bolwell BJ, Copelan EA. Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia. Br J Haematol 148:623-626, 2010.

Pant-Purohit M, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L. Small cell carcinoma of the urinary bladder. Histol Histopathol 25:217-221, 2010.

Paquette RL, Nicoll J, Chalukya M, Gondek L, Jasek M, Sawyers CL, Shah NP, Maciejewski J. Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib. Leuk Res 34:708-713, 2010.

Pareek TK, Lam E, Zheng X, Askew D, Kulkarni AB, Chance MR, Huang AY, Cooke KR, Letterio JJ. Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis. J Exp Med 207:2507-2519, 2010. PMCID: PMC2964575

Park DM, Sathornsumetee S, Rich JN. Medical oncology: treatment and management of malignant gliomas. Nat Rev Clin Oncol 7:75-77, 2010.

Park SB, Rhee FC, Monroe JI, Sohn JW. Spatially weighted mutual information image registration for image guided radiation therapy. Med Phys 37:4590-4601, 2010.

Pastorelli L, Garg RR, Hoang SB, Spina L, Mattioli B, Scarpa M, Fiocchi C, Vecchi M, Pizarro TT. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc Natl Acad Sci U S A 107:8017-8022, 2010. PMCID: PMC2867895

Pasupuleti N, Matsuyama S, Voss O, Doseff AI, Song K, Danielpour D, Nagaraj RH. The anti-apoptotic function of human aA-crystallin is directly related to its chaperone activity. Cell Death Dis 1:e31, 2010.

Patel AR, Chan ES, Hansel DE, Powell CT, Heston WD, Larchian WA. Transabdominal micro-ultrasound imaging of bladder cancer in a mouse model: a validation study. Urology 75:799-804, 2010.

Patel AR, Sabanegh ES, Jones JS, Gordon SM, Ballin M, Ruggieri PM, Stephenson AJ. Bacillus calmette-gurin osteomyelitis mimicking spinal metastasis from urothelial cell carcinoma of the bladder. Eur Urol 58:934-937, 2010.

Patel RB, Carlson AN, Solorio L, Exner AA. Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems. J Biomed Mater Res A 94:476-484, 2010. PMCID: PMC2914550

Patel RB, Solorio L, Wu H, Krupka T, Exner AA. Effect of injection site on in situ implant formation and drug release in vivo. J Control Release 147:350-358, 2010.

Patrick R, Buccini L, Kattan MW. Tailored cancer outcome prediction and informed consent. Semin Oncol 37:47-52, 2010.

Peereboom DM, Shepard DR, Ahluwalia MS, Brewer CJ, Agarwal N, Stevens GH, Suh JH, Toms SA, Vogelbaum MA, Weil RJ, Elson P, Barnett GH. Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. J Neurooncol 98:93-99, 2010.

Peereboom DM, Supko JG, Carson KA, Batchelor T, Phuphanich S, Lesser G, Mikkelson T, Fisher J, Desideri S, He X, Grossman SA; New Approaches to Brain Tumor Therapy (NABTT) Consortium. A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas. J Neurooncol 100:261-268, 2010.

Pea C, Lathia C, Shan M, Escudier B, Bukowski RM. Biomarkers predicting outcome in patients with advanced renal cell carcinoma: results from sorafenib phase III TARGET. Clin Cancer Res 16:4853-4863, 2010.

Peng A, Lewellyn A, Schiemann WP, Maller JL. Repo-man controls a protein phosphatase 1-dependet threshold for DNA damage checkpoint activation. Curr Biol 20:387-396, 2010. PMCID: PMC2860455

Penheiter SG, Deep Singh R, Repellin CE, Wilkes MC, Edens M, Howe PH, Pagano RE, Leof EB. Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2. Mol Biol Cell 21:4009-4019, 2010. PMCID: PMC2982134

Pennell NA, Govindan R. Time to move beyond clinical and pathologic classification of BAC. Oncology (Williston Park) 24:900-901, 2010.

Perry JR, Julian JA, Laperriere NJ, Geerts W, Agnelli G, Rogers LR, Malkin MG, Sawaya R, Baker R, Falanga A, Parpia S, Finch T, Levine MN. PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost 8:1959-1965, 2010.

Peterson LE, Litaker DG. County-level poverty is equally associated with unmet health care needs in rural and urban settings. J Rural Health 26:373-382, 2010.

Pham N, Fazio V, Cucullo L, Teng Q, Biberthaler P, Bazarian JJ, Janigro D. Extracranial sources of S100B do not affect serum levels. PLoS One 5:e12691, 2010. PMCID: PMC2937027

Pili R, Rosenthal MA, Mainwaring PN, Van Hazel G, Srinivas S, Dreicer R, Goel S, Leach J, Wong S, Clingan P. Phase II study on the addition of ASA404 (vadimezan; 5,6-dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC. Clin Cancer Res 16:2906-2914, 2010.

Platta CS, Khuntia D, Mehta MP, Suh JH. Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature. Am J Clin Oncol 33:398-407, 2010.

Plevka P, Hafenstein S, Harris KG, Cifuente JO, Zhang Y, Bowman VD, Chipman PR, Bator CM, Lin F, Medof ME, Rossmann MG. Interaction of decay-accelerating factor with echovirus 7. J Virol 84:12665-12674, 2010.

Pollack MJ, Cummings LC, Wong RC, Isenberg GA, Faulx AL, Chak A, Vargo JJ. Gender disparities and gastroenterology trainee attitudes toward advanced endoscopic training. Gastrointest Endosc 72:1111, 2010.

Portillo JA, Okenka G, Reed E, Subauste A, Van Grol J, Gentil K, Komatsu M, Tanaka K, Landreth G, Levine B, Subauste CS. The CD40-autophagy pathway is needed for host protection despite IFN-G-dependent immunity and CD40 induces autophagy via control of P21 levels. PLoS One 5:e14472, 2010.

Potters L, Roach M 3rd, Davis BJ, Stock RG, Ciezki JP, Zelefsky MJ, Stone NN, Fearn PA, Yu C, Shinohara K, Kattan MW. Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable. Int J Radiat Oncol Biol Phys 76:1061-1065, 2010.

Potts JM, Lutz M, Walker E, Modlin C, Klein E. Trends in PSA, age and prostate cancer detection among black and white men from 1990-2006 at a tertiary care center. Cancer 116:3910-3915, 2010.

Powell MA, Filiaci VL, Rose PG, Mannel RS, Hanjani P, Degeest K, Miller BE, Susumu N, Ueland FR. Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. J Clin Oncol 28:2727-2731, 2010. PMCID: PMC2881851

Prince-Paul M, Burant CJ, Saltzman JN, Teston LJ, Matthews CR. The effects of integrating an advanced practice palliative care nurse in a community oncology center: a pilot study. J Support Oncol 8:21-27, 2010.

Prince-Paul M, Exline JJ. Personal relationships and communication messages at the end of life. Nurs Clin North Am 45:449-463, 2010.

Prosdocimo DA, Wyler SC, Romani AM, O'Neill WC, Dubyak GR. Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia. Am J Physiol Cell Physiol 298:C702-713, 2010. PMCID: PMC2838579

Qiu X, Swanson P, Luk KC, Tu B, Villinger F, Das Gupta J, Silverman RH, Klein EA, Devare S, Schochetman G, Hackett J Jr. Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology 7:68, 2010. PMCID: PMC2931451

Qiu X, Zhao Y, Steward IM, Dyck JS, Burda C. Improvement of the thermoelectric power factor through anisotropic growth of nanostructured PbSe thin films. Dalton Trans 39:1095-1100, 2010.

Radivoyevitch T. How to use the computing environment R to analyze ATP-induced ribonucleotide reductase R1 hexamerization data. Nucleosides Nucleotides Nucleic Acids 29:427-432, 2010. PMCID: PMC2886286

Raghavan D. Bladder cancer: optimal application of preclinical models to suitable translational questions. Sci Transl Med 2:22ps11, 2010.

Rajab R, Fisher G, Kattan MW, Foster CS, Oliver T, Mller H, Reuter V, Scardino P, Cuzick J, Berney DM; Transatlantic Prostate Group. Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort. Virchows Arch 457:547-553, 2010.

Ramachandra L, Qu Y, Wang Y, Lewis CJ, Cobb BA, Takatsu K, Boom WH, Dubyak GR, Harding CV. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation. Infect Immun 78:5116-5125, 2010. PMCID: PMC2981298

Rana S, Gupta K, Gomez J, Matsuyama S, Chakrabarti A, Agarwal ML, Agarwal A, Agarwal MK, Wald DN. Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells. FASEB J 24:2126-2134, 2010.

Rane A, Ponsky LE, Richstone L. Minimally invasive surgery in urology: is the winner natural-orifice translumenal endoscopic surgery or laparoendoscopic single-site surgery? BJU Int 106:1-2, 2010.

Rani MR, Croze E, Wei T, Shrock J, Josyula A, Kalvakolanu DV, Ransohoff RM. STAT-phosphorylation-independent induction of interferon regulatory factor-9 by interferon-beta. J Interferon Cytokine Res 30:163-170, 2010.

Ransohoff RM, Cardona AE. The myeloid cells of the central nervous system parenchyma. Nature 468:253-262, 2010.

Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med 38(4 Suppl):S502-S509, 2010.

Rasool N, Fader AN, Seamon L, Neubauer NL, Shahin FA, Alexander HA, Moore K, Moxley K, Secord AA, Kunos C, Rose PG, O'Malley DM. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence. Gynecol Oncol 116:10-14, 2010.

Rasool N, Rose PG. Fertility-preserving surgical procedures for patients with gynecologic malignancies. Clin Obstet Gynecol 53:804-814, 2010.

Reddy M, Torres G, McCormick T, Marano C, Cooper K, Yeilding N, Wang Y, Pendley C, Prabhakar U, Wong J, Davis C, Xu S, Brodmerkel C. Positive treatment effects of ustekinumab in psoriasis: analysis of lesional and systemic parameters. J Dermatol 37:413-425, 2010.

Reineke EL, Liu Y, Kao HY. Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1. J Biol Chem 285:9485-9492, 2010. PMCID: PMC2843199

Reiners JJ Jr, Agostinis P, Berg K, Oleinick NL, Kessel D. Assessing autophagy in the context of photodynamic therapy. Autophagy 6:7-18, 2010. PMCID: PMC2861993

Ren B, Deng Y, Mukhopadhyay A, Lanahan AA, Zhuang ZW, Moodie KL, Mulligan-Kehoe MJ, Byzova TV, Peterson RT, Simons M. ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J Clin Invest 120:1217-1228, 2010. PMCID: PMC2846043

Ren X, Xu C, Zhan C, Yang Y, Shi L, Wang F, Wang C, Xia Y, Yang B, Wu G, Wang P, Li X, Wang D, Xiong X, Liu J, Liu Y, Liu M, Liu J, Tu X, Wang QK. Identification of NPPA variants associated with atrial fibrillation in a Chinese GeneID population. Clin Chim Acta 411:481-485, 2010.

Reuter MA, Pecora ND, Harding CV, Canaday DH, McDonald D. Mycobacterium tuberculosis promotes HIV trans-infection and suppresses MHC-II antigen processing by dendritic cells. J Virol 84:8549-8560, 2010. PMCID: PMC2919047

Rieder F, Fiocchi C. First international summit on fibrosis in intestinal inflammation: mechanisms and biological therapies. Fibrogenesis Tissue Repair 3:22, 2010. PMCID: PMC2989302

Rini BI, Garcia JA, Cooney MM, Elson P, Tyler A, Beatty K, Bokar J, Ivy P, Chen HX, Dowlati A, Dreicer R. Toxicity of sunitinib plus bevacizumab in renal cell carcinoma. J Clin Oncol 28:e284-e285, 2010. PMCID: PMC2903321

Rini BI, Halabi S, Rosenberg JE, Stadler WM, Vaena DA, Archer L, Atkins JN, Picus J, Czaykowski P, Dutcher J, Small EJ. Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206. J Clin Oncol 28:2137-2143, 2010. PMCID: PMC2860433

Rini BI, Shah SN. Editorial comment [The loss of radiographic enhancement in primary renal cell carcinoma tumors following multitargeted receptor tyrosine kinase therapy is an additional indicator of response]. Urology 75:1114-1115, 2010.

Rini BI. Biomarkers: hypertension following anti-angiogenesis therapy. Clin Adv Hematol Oncol 8:415-416, 2010.

Rini BI. New strategies in kidney cancer: therapeutic advances through understanding the molecular basis of response and resistance. Clin Cancer Res 16:1348-1354, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Determining the yield and quality of purified RNA. Cold Spring Harb Protoc 2010:pdb.top82, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Enrichment of poly(A)+ mRNA using immobilized oligo(dT). Cold Spring Harb Protoc 2010:pdb.prot5454, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Ethanol precipitation of RNA and the use of carriers. Cold Spring Harb Protoc 2010:pdb.prot5440, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Guidelines for the use of RNA purification kits. Cold Spring Harb Protoc 2010:pdb.ip79, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Nondenaturing agarose gel electrophoresis of RNA. Cold Spring Harb Protoc 2010:pdb.prot5445, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Polyacrylamide gel electrophoresis of RNA. Cold Spring Harb Protoc 2010:pdb.prot5444, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Preparation of cytoplasmic and nuclear RNA from tissue culture cells. Cold Spring Harb Protoc 2010:pdb.prot5441, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Purification of RNA by SDS solubilization and phenol extraction. Cold Spring Harb Protoc 2010:pdb.prot5438, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb Protoc 2010:pdb.prot5439, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Removal of DNA from RNA. Cold Spring Harb Protoc 2010:pdb.prot5443, 2010.

Rio DC, Ares M Jr, Hannon GJ, Nilsen TW. Removal of ribosomal subunits (and rRNA) from cytoplasmic extracts before solubilization with SDS and deproteinization. Cold Spring Harb Protoc 2010:pdb.prot5442, 2010.

Rixe O, Rini B. Renal cell carcinoma: ten years of significant advances. Target Oncol 5:73-74, 2010.

Rizzieri D, Lorusso S, Tse W, Khan K, Advani A, Moore J, Karsten V, Cahill A, Gerson SL. Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemia. Clin Lymphoma Myeloma Leuk 10:211-216, 2010.

Robertson LB, Armstrong GN, Olver BD, Lloyd AL, Shete S, Lau C, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Yang P, Rynerason AL, Wrensch M, McCoy L, Wienkce JK, McCarthy B, Davis F, Vick NA, Johansen C, Bdtcher H, Sadetzki S, Bruchim RB, Yechezkel GH, Andersson U, Melin BS, Bondy ML, Houlston RS. Survey of familial glioma and role of germline p16 ( INK4A ) /p14 ( ARF ) and p53 mutation. Fam Cancer 9:413-421, 2010. PMCID: PMC2922430

Robinson CG, Palomo JM, Rahmathulla G, McGraw M, Donze J, Liu L, Vogelbaum MA. Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA methyltransferase activity and survival. Br J Cancer 103:498-504, 2010. PMCID: PMC2939788

Robinson C, Palomo J, Vogelbaum MA. Thin layer chromatography-based assay of O6-methylguanine-DNA methyltransferase activity in tissue. Anal Biochem 405:263-265, 2010.

Robinson CG, Polster JM, Reddy CA, Lyons JA, Evans PJ, Lawton JN, Graham TJ, Suh JH. Postoperative single-fraction radiation for prevention of heterotopic ossification of the elbow. Int J Radiat Oncol Biol Phys 77:1493-1499, 2010.

Rodriguez A, Anderson JM. Evaluation of clinical biomaterial surface effects on T lymphocyte activation. J Biomed Mater Res A 92:214-220, 2009. PMCID: PMC2788042

Rodriguez CP, Adelstein DJ, Rice TW, Rybicki LA, Videtic GM, Saxton JP, Murthy SC, Mason DP, Ives DI. A Phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer. J Thorac Oncol 5:229-235, 2010.

Rodriguez CP, Adelstein DJ. Survival trends in head and neck cancer: opportunities for improving outcomes. Oncologist 15:921-923, 2010.

Rodriguez ME, Kim J, Delos Santos GB, Azizuddin K, Berlin J, Anderson VE, Kenney ME, Oleinick NL. Binding to and photo-oxidation of cardiolipin by the phthalocyanine photosensitizer Pc 4. J Biomed Opt 15:051604, 2010. PMCID: PMC2945736

Rogers L, Gilbert M, Vogelbaum MA. Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol 99:393-405, 2010.

Rogers LR. Cerebrovascular complications in patients with cancer. Semin Neurol 30:311-319, 2010.

Rose PG, Ali S, Whitney CW, Lanciano R, Stehman FB. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol 117:270-275, 2010.

Rose PG, Tian C, Bookman MA. Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 117:324-329, 2010.

Rosenfeld MR, Chamberlain MC, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X. A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. Neuro Oncol 12:1071-1077, 2010.

Ross HJ, Blumenschein GR Jr, Aisner J, Damjanov N, Dowlati A, Garst J, Rigas JR, Smylie M, Hassani H, Allen KE, Leopold L, Zaks TZ, Shepherd FA. Randomized Phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer. Clin Cancer Res 16:1938-1949, 2010.

Rowe JM, Kim HT, Cassileth PA, Lazarus HM, Litzow MR, Wiernik PH, Tallman MS. Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group. Cancer 116:5012-5021, 2010.

Roy D, Gargesha M, Steyer GJ, Hakimi P, Hanson RW, Wilson DL. Multi-scale characterization of the PEPCK-C mouse through 3D cryo-imaging. Int J Biomed Imaging 2010:105984, 2010. PMCID: PMC2868186

Rubin BP, Antonescu CR, Gannon FH, Hunt JL, Inwards CY, Klein MJ, Kneisl JS, Montag AG, Peabody TD, Reith JD, Rosenberg AE, Krausz T; Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with tumors of bone. Arch Pathol Lab Med 134:e1-e7, 2010.

Rubin BP, Blanke CD, Demetri GD, Dematteo RP, Fletcher CD, Goldblum JR, Lasota J, Lazar A, Maki RG, Miettinen M, Noffsinger A, Washington MK, Krausz T; Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with gastrointestinal stromal tumor. Arch Pathol Lab Med 134:165-170, 2010.

Rubin BP, Cooper K, Fletcher CD, Folpe AL, Gannon FH, Hunt JL, Lazar AJ, Montag AG, Peabody TD, Pollock RE, Reith JD, Qualman SJ, Rosenberg AE, Weiss SW, Krausz T; Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with tumors of soft tissue. Arch Pathol Lab Med 134:e31-e39, 2010.

Rubin BP, Debnath J. Therapeutic implications of autophagy-mediated cell survival in gastrointestinal stromal tumor after treatment with imatinib mesylate. Autophagy 6:1190-1191, 2010.

Rubin BP. Bioinformatic mining of gene expression datasets identifies ETV1 as a critical regulator of oncogenesis in gastrointestinal stromal tumors. Cancer Cell 18:407-408, 2010.

Rutkowski P, Van Glabbeke M, Rankin CJ, Ruka W, Rubin BP, Debiec-Rychter M, Lazar A, Gelderblom H, Sciot R, Lopez-Terrada D, Hohenberger P, van Oosterom AT, Schuetze SM. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol 28:1772-1779, 2010.

Ryan S, Verghese S, Cianciola NL, Cotton CU, Carlin CR. Autosomal recessive polycystic kidney disease epithelial cell model reveals multiple basolateral EGF receptor sorting pathways. Mol Biol Cell 21:2732-2745, 2010. PMCID: PMC2912358

Sabens EA, Distler AM, Mieyal JJ. Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease. Biochemistry 49:2715-2724, 2010.

Sadhukhan S, Han Y, Zhang GF, Brunengraber H, Tochtrop GP. Using isotopic tools to dissect and quantitate parallel metabolic pathways. J Am Chem Soc 132:6309-6311, 2010.

Saikia P, Fensterl V, Sen GC. The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication. J Virol 84:13036-13039, 2010.

Sakuma M, Morooka T, Wang Y, Shi C, Croce K, Gao H, Strainic M, Medof ME, Simon DI. The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury. Arterioscler Thromb Vasc Biol 30:1196-1202, 2010. PMCID: PMC2903214

Sakuma R, Sakuma T, Ohmine S, Silverman RH, Ikeda Y. Xenotropic murine leukemia virus-related virus is susceptible to AZT. Virology 397:1-6, 2010. PMCID: PMC2821880

Samano AK, Ohshima-Hosoyama S, Whitney TG, Prajapati SI, Kilcoyne A, Taniguchi E, Morgan WW, Nelon LD, Lin AL, Togao O, Jung I, Rubin BP, Nowak BM, Duong TQ, Keller C. Functional evaluation of therapeutic response for a mouse model of medulloblastoma. Transgenic Res 19:829-840, 2010.

Sampson JH, Archer G, Pedain C, Wembacher-Schrder E, Westphal M, Kunwar S, Vogelbaum MA, Coan A, Herndon JE, Raghavan R, Brady ML, Reardon DA, Friedman AH, Friedman HS, Rodrguez-Ponce MI, Chang SM, Mittermeyer S, Croteau D, Puri RK; PRECISE Trial Investigators. Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 113:301-309, 2010.

Sanders SL, Arida AR, Phan FP. Requirement for the phospho-H2AX binging module of Crb2 in double-strand break targeting and checkpoint activation. Mol Cell Biol 30:4722-4731, 2010. PMCID: PMC2950520

Sandhu GS, Solorio L, Broome AM, Salem N, Kolthammer J, Shah T, Flask C, Duerk JL. Whole animal imaging. Wiley Interdiscip Rev Syst Biol Med 2:398-421, 2010.

Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Lopez-Beltran A, Oliva E, Paner GP, Reuter VE, Ro JY, Shah RB, Shen SS, Tamboli P, McKenney JK. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the rrinary tract among urologic pathologists. Am J Surg Pathol 34:1367-1376, 2010.

Satake N, Ohori M, Yu C, Kattan MW, Ohno Y, Miyakawa A, Hatano T, Tachibana M. Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimens. Int J Urol 17:267-272, 2010.

Sathornsumetee S, Desjardins A, Vredenburgh JJ, McLendon RE, Marcello J, Herndon JE, Mathe A, Hamilton M, Rich JN, Norfleet JA, Gururangan S, Friedman HS, Reardon DA. Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma. Neuro Oncol 12:1300-1310, 2010.

Sawyer MD, Ponsky LE. Technical and equipment challenges for laparoendoscopic single-site surgery and natural orifice transluminal endoscopic surgery. BJU Int 06(6 Pt B):892-896, 2010.

Schaffer BS, Grayson MH, Wortham JM, Kubicek CB, McCleish AT, Prajapati SI, Nelon LD, Brady MM, Jung I, Hosoyama T, Sarro LM, Hanes MA, Rubin BP, Michalek JE, Clifford CB, Infante AJ, Keller C. Immune competency of a hairless mouse strain for improved preclinical studies in genetically engineered mice. Mol Cancer Ther 9:2354-2364, 2010. PMCID: PMC2921575

Scheurer ME, Etzel CJ, Liu M, Barnholtz-Sloan J, Wiklund F, Tavelin B, Wrensch MR, Melin BS, Bondy ML; GLIOGENE Consortium. Familial aggregation of glioma: a pooled analysis. Am J Epidemiol 172:1099-1107, 2010.

Schmaier AH. Oscar D. Ratnoff: a man for all seasons. Thromb Haemost 104:863-866, 2010.

Schneider T, Karl S, Moore LR, Chalmers JJ, Williams PS, Zborowski M. Sequential CD34 cell fractionation by magnetophoresis in a magnetic dipole flow sorter. Analyst 135:62-70, 2010.

Schnetz MP, Handoko L, Akhtar-Zaidi B, Bartels CF, Pereira CF, Fisher AG, Adams DJ, Flicek P, Crawford GE, Laframboise T, Tesar P, Wei CL, Scacheri PC. CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet 6:e1001023, 2010. PMCID: PMC2904778

Schnipper LE, Meropol NJ, Brock DW. Value and cancer care: toward an equitable future. Clin Cancer Res 16:6004-6008, 2010.

Schold JD, Srinivas TR, Poggio ED, Stephany BR, Flechner SM, Goldfarb DA, Kattan MW. Hidden selection bias deriving from donor organ characteristics does not affect performance evaluations of kidney transplant centers. Med Care 48:907-914, 2010.

Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, Marks DI, Rizzo JD, Pasquini MC. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant 16:1099-1106, 2010. PMCID: PMC2897953

Schroeck FR, Kattan MW, Moul JW, Aronson WJ, Presti Jr JC, Terris MK, Kane CJ, Amling CL, Sun L, Freedland SJ. Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy. BJU Int 105:1654-1659, 2010.

Sekeres MA, List AF, Cuthbertson D, Paquette R, Ganetsky R, Latham D, Paulic K, Afable M, Saba HI, Loughran TP Jr, Maciejewski JP. Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromes. J Clin Oncol 28:2253-2258, 2010. PMCID: PMC2860439

Sekeres MA. Henry Kaplan and the story of Hodgkin's disease' by Charlotte DeCroes Jacobs. Oncol Times 32:21-22, 2010.

Sekeres MA. A Hallmark moment. J Clin Oncol 28:5348-5349, 2010.

Sekeres MA. Are we nearer to curing patients with MDS? Best Pract Res Clin Haematol 23:481-487, 2010.

Sekeres MA. How flipping burgers can cure leukemia. J Clin Oncol 28:3096-3097, 2010.

Sekeres MA. Second thoughts from Sekeres: baby steps or giant leaps for cancer drug approval? Oncol Times 32:14, 2010.

Sekeres MA. Second thoughts from Sekeres: informed enough...the limits to informed consent. Oncol Times 32:8, 2010.

Sekeres MA. Second thoughts from Sekeres: meta than nothingwhat to make of meta-analyses of cancer risk. Oncol Times 32:19-20, 2010.

Sekeres MA. Second thoughts from Sekeres: waiting for Godot: why we need phase 3 trials for cancer drugs. Oncol Times 32:21, 2010.

Sekeres MA. The epidemiology of myelodysplastic syndromes. Hematol Oncol Clin North Am 24:287-294, 2010.

Seliger B, Massa C, Rini B, Ko J, Finke J. Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors. Trends Mol Med 16:184-192, 2010.

Seong IS, Woda JM, Song JJ, Lloret A, Abeyrathne PD, Woo CJ, Gregory G, Lee JM, Wheeler VC, Walz T, Kingston RE, Gusella JF, Conlon RA, Macdonald ME. Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet 19:573-583, 2010. PMCID: PMC2807366

Sha J, Ghosh MK, Zhang K, Harter ML. E1A interacts with two opposing transcriptional pathways to induce quiescent cells into S phase. J Virol 84:4050-4059, 2010. PMCID: PMC2849484

Shaheen NJ, Peery AF, Overholt BF, Lightdale CJ, Chak A, Wang KK, Hawes RH, Fleischer DE, Goldblum JR; AIM Dysplasia Investigators. Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus. Gastrointest Endosc 72:490-496.e1, 2010.

Shaheen PE, Legrand SB, Walsh D, Estfan B, Davis MP, Lagman RL, Riaz M, Cheema B. Errors in opioid prescribing: a prospective survey in cancer pain. J Pain Symptom Manage 39:702-711, 2010.

Shaked H, Wachtel C, Tulinski P, Yahia NH, Barda O, Darzynkiewicz E, Nilsen TW, Michaeli S. Establishment of an in vitro trans-splicing system in Trypanosoma brucei that requires endogenous spliced leader RNA. Nucleic Acids Res 38:e114, 2010. PMCID: PMC2879531

Shamberger RC, Anderson JR, Breslow NE, Perlman EJ, Beckwith JB, Ritchey ML, Haase GM, Donaldson M, Grundy PE, Weetman R, Coppes MJ, Malogolowkin M, Shearer PD, Kletzel M, Thomas PR, Macklis R, Huff V, Weeks DA, Green DM. Long-term outcomes for infants with very low risk Wilms tumor treated With surgery alone in national Wilms tumor study-5. Ann Surg251:555-558, 2010. PMCID: PMC2836016

Shao H, Sinasac DS, Burrage LC, Hodges CA, Supelak PJ, Palmert MR, Moreno C, Cowley AW Jr, Jacob HJ, Nadeau JH. Analyzing complex traits with congenic strains. Mamm Genome 21:276-286, 2010.

Shaughnessy PJ, Bolwell BJ, van Besien K, Mistrik M, Grigg A, Dodds A, Prince HM, Durrant S, Ilhan O, Parenti D, Gallo J, Foss F, Apperley J, Zhang MJ, Horowitz MM, Abhyankar S. Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 45:1068-1076, 2010.

Sheehan JP, Shaffrey ME, Gupta B, Larner J, Rich JN, Park DM. Improving the radiosensitivity of radioresistant and hypoxic glioblastoma. Future Oncol 6:1591-1601, 2010.

Shepard DR, Dreicer R. Zibotentan for the treatment of castrate-resistant prostate cancer. Expert Opin Investig Drugs 19:899-908, 2010.

Shepard DR, Raghavan D. Innovations in the systemic therapy of prostate cancer. Nat Rev Clin Oncol 7:13-21, 2010.

Sheykholeslami K, Rezaee R, Lavertu P. Percutaneous tracheotomy. Atlas Oral Maxillofac Surg Clin North Am 18:51-60, 2010.

Shi T, Mazumdar T, Devecchio J, Duan ZH, Agyeman A, Aziz M, Houghton JA. cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells. PLoS One 5:e13054, 2010. PMCID: PMC2948497

Shi W, Bohon J, Han D, Habte H, Qin Y, Cho MW, Chance MR. Structural characterization of HIV GP41 with the membrane proximal external region. J Biol Chem 285:24290-24298, 2010. PMCID: PMC2911339

Shiovitz S, Everett J, Huang SC, Orloff MS, Eng C, Gruber SB. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer. Breast Cancer Res Treat 124:459-465, 2010.

Shoskes DA, Nickel JC, Kattan MW. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 75(6):1249-1253, 2010.

Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962-978, 2010. PMCID: PMC2874462

Siebold AP, Banerjee R, Tie F, Kiss DL, Moskowitz J, Harte PJ. Polycomb repressive complex 2 and trithorax modulate Drosophila longevity and stress resistance. Proc Natl Acad Sci U S A 107:169-174, 2010. PMCID: PMC2806727

Silva IA, Olkiewicz K, Askew D, Fisher JM, Chaudhary MN, Vannella KM, Deurloo DT, Choi SW, Pierce E, Clouthier SG, Liu C, Cooke KR. Secondary lymphoid organs contribute to, but are not required for the induction of Graft-versus-Host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation. Biol Blood Marrow Transplant 16:598-611, 2010.

Silverman RH, Nguyen C, Weight CJ, Klein EA. The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. Nat Rev Urol 7:392-402, 2010.

Silverstein RL, Li W, Park YM, Rahaman SO. Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis. Trans Am Clin Climatol Assoc 121:206-220, 2010. PMCID: PMC2917163

Singh N, Singh A, Das D, Mohan M. Redox control of prion and disease pathogenesis. Antioxid Redox Signal 12:1271-1294, 2010. PMCID: PMC2864664

Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol 11:627-636, 2010.

Sipahi I, Simon DI, Fang JC. Angiotensin-receptor blockade, cancer, and concerns - Authors' reply. Lancet Oncol 11:821-822, 2010.

Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 362:600-613, 2010. PMCID: PMC2951321

Sloand EM, Pfannes L, Ling C, Feng X, Jasek M, Calado R, Tucker ZC, Hematti P, Maciejewski J, Dunbar C, Barrett J, Young N. Graft-versus-host disease: role of inflammation in the development of chromosomal abnormalities of keratinocytes. Biol Blood Marrow Transplant 16:1665-1673, 2010.

Sloand EM, Olnes MJ, Weinstein B, Wu C, Maciejewski J, Scheinberg P, Young NS. Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab. Haematologica 95:382-387, 2010. PMCID: PMC2833067

Smieszek S, Richter R, Przychodzen B, Maciejewski J. Silicosection and elucidation of the plant circadian clock using bayesian classifiers and new genemining algorithm. Adv Exp Med Biol 680:43-56, 2010.

Smith AD, Shah SN, Rini BI, Lieber ML, Remer EM. Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. AJR Am J Roentgenol 194:1470-1478, 2010.

Smith AE, Mohamedali AM, Kulasekararaj A, Lim Z, Gken J, Lea NC, Przychodzen B, Mian SA, Nasser EE, Shooter C, Westwood NB, Strupp C, Gattermann N, Maciejewski JP, Germing U, Mufti GJ. Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. Blood 116:3923-3932, 2010.

Smith L, Page RC, Xu Z, Kohli E, Litman P, Nix JC, Ithychanda SS, Liu J, Qin J, Misra S, Liedtke CM. Biochemical basis of the interaction between cystic fibrosis transmembrane conductance regulator (CFTR) and immunoglobulin-like repeats of filamin. J Biol Chem 285:17166-17176, 2010. PMCID: PMC2878048

Smith SD, Hsi E, Bolwell B, Pohlman B, Dean R, Effinger M, Maggiotto A, Sweetenham J. Validation of the mantle cell lymphoma international prognostic index: a single-center retrospective analysis. Am J Hematol 85:454-456, 2010.

Smith SD, Sweetenham JW. Intensive therapies for mantle cell lymphoma: time for a disease-specific approach? Leuk Lymphoma 51:357-359, 2010.

Snow DC, Klein EA. Use of nomograms for early detection in prostate cancer. J Natl Compr Canc Netw 8:271-276, 2010.

Solchaga LA, Penick K, Goldberg VM, Caplan AI, Welter JF. Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone marrow-derived mesenchymal stem cells. Tissue Eng Part A 16:1009-1019, 2010. PMCID: PMC2862658

Solorio L, Babin BM, Patel RB, Mach J, Azar N, Exner AA. Noninvasive characterization of in situ forming implants using diagnostic ultrasound. J Control Release 143:183-190, 2010. PMCID: PMC2847659

Song BJ, Elbert A, Rahman T, Orr SK, Chen CT, Febbraio M, Bazinet RP. Genetic ablation of CD36 does not alter mouse brain polyunsaturated fatty acid concentrations. Lipids 45:291-299, 2010.

Song K, Wang H, Krebs TL, Wang B, Kelley TJ, Danielpour D. DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells. Mol Endocrinol 24:2019-2029, 2010. PMCID: PMC2954637

Song MJ, Dean D, Knothe Tate ML. In situ spatiotemporal mapping of flow fields around seeded stem cells at the subcellular length scale. PLoS One 5:e12796, 2010. PMCID: PMC2941457

Sorrell JM, Caplan AI. Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther 1:30, 2010. PMCID: PMC2983443

Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655-661, 2010.

Spratlin JL, Cohen RB, Eadens M, Gore L, Camidge DR, Diab S, Leong S, O'Bryant C, Chow LQ, Serkova NJ, Meropol NJ, Lewis NL, Chiorean EG, Fox F, Youssoufian H, Rowinsky EK, Eckhardt SG. Phase I pharmacologic and biologic study of Ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2. J Clin Oncol 28:780-787, 2010. P MCID: PMC2834394

Sproat L, Bolwell B, Rybicki L, Tench S, Chan J, Kalaycio M, Dean R, Sobecks R, Pohlman B, Andresen S, Sweetenham J, Copelan E. Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission. Leuk Lymphoma 51:1699-1704, 2010.

Srigley JR, Amin MB, Delahunt B, Campbell SC, Chang A, Grignon DJ, Humphrey PA, Leibovich BC, Montironi R, Renshaw AA, Reuter VE; Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. Arch Pathol Lab Med 134:e25-e30, 2010.

Srivastava JK, Shankar E, Gupta S. Chamomile: a herbal medicine of the past with bright future. Mol Med Report 3:895-901, 2010. PMCID: PMC2995283

Stadler WM, Figlin RA, McDermott DF, Dutcher JP, Knox JJ, Miller WH Jr, Hainsworth JD, Henderson CA, George JR, Hajdenberg J, Kindwall-Keller TL, Ernstoff MS, Drabkin HA, Curti BD, Chu L, Ryan CW, Hotte SJ, Xia C, Cupit L, Bukowski RM; ARCCS Study Investigators. Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America. Cancer 116:1272-1280, 2010.

Stange KC, Miller WL, Nutting PA, Crabtree BF, Stewart EE, Jan CR. Context for understanding the National Demonstration Project and the patient-centered medical home. Ann Fam Med 8(Suppl 1):S2-S8, 2010. PMCID: PMC2885730

Stange KC, Nutting PA, Miller WL, Jan CR, Crabtree BF, Flocke SA, Gill JM. Defining and measuring the patient-centered medical home. J Gen Intern Med 25:601-612, 2010. PMCID: PMC2869425

Stange KC. Ethics, support for care, prevention, and what's important. Ann Fam Med 8:290-291, 2010. PMCID: PMC2906521

Stange KC. Power to advocate for health. Ann Fam Med 8:100-107, 2010. PMCID: PMC2834716

Stange KC. Receptor sites for the primary care function: reaction to the paper by Karen Davis, PhD, and Kristof Stremikis, MPP. J Am Board Fam Med 23(Suppl 1):S17-S20, 2010.

Stange KC. Ways of knowing, learning, and developing. Ann Fam Med 8:4-10, 2010. PMCID: PMC2807381

Stavrou E, Schmaier AH. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Thromb Res 125:210-215, 2010. PMCID: PMC2851158

Steinmetz NF, Mertens ME, Taurog RE, Johnson JE, Commandeur U, Fischer R, Manchester M. Potato virus X as a novel platform for potential biomedical applications. Nano Lett 10:305-312, 2010. PMCID: PMC2958517

Steinmetz NF. Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine 6:634-641, 2010. PMCID: PMC2948632

Stephans KL, Xia P, Tendulkar RD, Ciezki JP. The current status of image-guided external beam radiotherapy for prostate cancer. Curr Opin Urol 20:223-228, 2010.

Stephenson A. Current opinion in urology: editorial introduction. Curr Opin Urol 20:vii, 2010.

Stephenson AJ, Abouassaly R, Klein EA. Chemoprevention of prostate cancer. Urol Clin North Am 37:11-21, 2010.

Stephenson AJ, Gong MC, Campbell SC, Fergany AF, Hansel DE. Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. Urology 75:382-386, 2010.

Stephenson AJ. Chemoprevention of prostate cancer. Community Oncol 7(5 Suppl 2):28-30, 2010.

Steinmetz NF. Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine 6:634-641, 2010. PMCID: PMC2948632

Stewart EE, Nutting PA, Crabtree BF, Stange KC, Miller WL, Jan CR. Implementing the patient-centered medical home: observation and description of the national demonstration project. Ann Fam Med 8 Suppl 1:S21-32, 2010. PMCID: PMC2885725

Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21:128-138, 2010.

Stiff PJ, Agovi MA, Antman KH, Blaise D, Camitta BM, Cairo MS, Childs RW, Edwards JR, Gale RP, Hale GA, Lazarus HM, Arora M. High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma. Biol Blood Marrow Transplant 16:525-532, 2010. PMCID: PMC2838953

Stitzenberg KB, Meropol NJ. Trends in centralization of cancer surgery. Ann Surg Oncol 17:2824-2831, 2010.

Stotler C, Bolwell B, Sobecks R, Dean R, Serafino S, Rybicki L, Andresen S, Pohlman B, Kalaycio M, Copelan E. Are backup BM harvests worthwhile in unrelated donor allogeneic transplants? Bone Marrow Transplant 45:49-52, 2010.

Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 303:2479-2485, 2010.

Su B, Wang X, Lee HG, Tabaton M, Perry G, Smith MA, Zhu X. Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neurosci Lett 468:267-271, 2010.

Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta 1802:135-142, 2010. PMCID: PMC2790543

Subramanian S, Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PC, Corless CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CD, van de Rijn M. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol 220:58-70, 2010.

Subramanian VS, Nguyen CT, Stephenson AJ, Klein EA. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. Urol Oncol 28:504-509, 2010.

Sugimoto Y, Muramatsu H, Makishima H, Prince C, Jankowska AM, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations. Br J Haematol 150:83-87, 2010.

Suh JH, Videtic GM, Aref AM, Germano I, Goldsmith BJ, Imperato JP, Marcus KJ, McDermott MW, McDonald MW, Patchell RA, Robins HI, Rogers CL, Wolfson AH, Wippold FJ, Gaspar LE. ACR Appropriateness Criteria: single brain metastasis. Curr Probl Cancer 34:162-174, 2010.

Suh JH. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 362:1119-1127, 2010.

Suh JH. The author replies [Stereotactic radiosurgery for the management of brain metastases]. N Engl J Med 363:592-593, 2010.

Sulmasy DP, Astrow AB, He MK, Seils DM, Meropol NJ, Micco E, Weinfurt KP. The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer 116:3702-3711, 2010.

Sun W, Davis PB. Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism. J Control Release 146:118-127, 2010.

Sun X, Elston R, Barnholtz-Sloan J, Falk G, Grady WM, Kinnard M, Mittal SK, Willis JE, Markowitz S, Brock W, Chak A. A segregation analysis of Barrett's esophagus and associated adenocarcinomas. Cancer Epidemiol Biomarkers Prev 19:666-674, 2010. PMCID: PMC2838211

Sweetenham JW, Goldman B, Leblanc ML, Cook JR, Tubbs RR, Press OW, Maloney DG, Fisher RI, Rimsza LM, Braziel RM, Hsi ED. Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study. Ann Oncol 21:1196-1202, 2010. PMCID: PMC2875547

Swoboda RK, Somasundaram R, Caputo L, Berencsi K, von Franzke P, Taylor DD, Marincola FM, Meropol NJ, Sigurdson E, Miller E, Herlyn D. Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient. Int J Cancer 127:1124-1130, 2010. PMCID: PMC2897913

Sy MS, Li C, Yu S, Xin W. The fatal attraction between pro-prion and filamin A: prion as a marker in human cancers. Biomark Med 4:453-464, 2010. PMCID: PMC2925173

Szpurka H, Jankowska AM, Makishima H, Bodo J, Bejanyan N, Hsi ED, Sekeres MA, Maciejewski JP. Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. Leuk Res 34:969-973, 2010. PMCID: PMC2953471

Tadmor T, Polliack A, Sweetenham J. Ocular adnexal mucosa-associated lymphoid tissue lymphomas: more clues but still a puzzle. Leuk Lymphoma 51:1951-1953, 2010.

Tadmor T, Polliack A, Sweetenham J. Posttransplant lymphoproliferative disorder after living donor liver transplant: are we improving incidence and outcome? Leuk Lymphoma 51:1393-1394, 2010.

Talantov D, Jatkoe TA, Bhm M, Zhang Y, Ferguson AM, Stricker PD, Kattan MW, Sutherland RL, Kench JG, Wang Y, Henshall SM. Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy. J Urol 184:1521-1528, 2010.

Tan K, Lessieur E, Cutler A, Nerone P, Vasanji A, Asosingh K, Erzurum S, Anand-Apte B. Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy. Exp Eye Res 91:229-237, 2010.

Tan M, Wu X, Jeong EK, Chen Q, Lu ZR. Peptide-targeted nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging. Biomacromolecules 11:754-761, 2010. PMCID: PMC2852882

Tan M, Wu X, Jeong EK, Chen Q, Parker DL, Lu ZR. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix. Mol Pharm 7:936-943, 2010. PMCID: PMC2914142

Tanagho Y, Stovsky M, Maclennan GT. Testicular plasmacytoma. J Urol 184:1161-1162, 2010.

Tanas MR, Rubin BP, Montgomery EA, Turner SL, Cook JR, Tubbs RR, Billings SD, Goldblum JR. Utility of FISH in the diagnosis of angiomatoid fibrous histiocytoma: a series of 18 cases. Mod Pathol 23:93-97, 2010.

Tanas MR, Rubin BP, Tubbs RR, Billings SD, Downs-Kelly E, Goldblum JR. Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience. Arch Pathol Lab Med 134:1797-1803, 2010.

Tartakoff AM, Tao T. Comparative and evolutionary aspects of macromolecular translocation across membranes. Int J Biochem Cell Biol 42:214-229, 2010.

Taylor MA, Parvani JG, Schiemann WP. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia 15:169-190, 2010.

Tebit DM, Lobritz M, Lalonde M, Immonen T, Singh K, Sarafianos S, Herchenrder O, Krusslich HG, Arts EJ. Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. J Virol 84:9817-9830, 2010. PMCID: PMC2937803

Thakur VS, Ruhul Amin AR, Paul RK, Gupta K, Hastak K, Agarwal MK, Jackson MW, Wald DN, Mukhtar H, Agarwal ML. p53-dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG. Cancer Lett 296:225-232, 2010. PMCID: PMC2914167

Thompson CL, Plummer SJ, Tucker TC, Casey G, Li L. Interleukin-22 genetic polymorphisms and risk of colon cancer. Cancer Causes Control 21:1165-1170, 2010.

Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 58:340-345, 2010.

Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Campbell SC, Blute ML. Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol 58:331-336, 2010.

Tian M, Schiemann WP. PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis. FASEB J 24:1105-1116, 2010. PMCID: PMC2845432

Tiu RV, Singh AD, Workman J, Cotta CV, Sweetenham JW. Concomitant conjunctival mucosa-associated lymphoid tissue lymphoma and small lymphocytic lymphoma associated with immunoglobulin M macroglobulinemia successfully treated with intensity modulated radiation therapy. Leuk Lymphoma 51:952-955, 2010.

Tomsic J, Guda K, Liyanarachchi S, Hampel H, Natale L, Markowitz SD, Tanner SM, de la Chapelle A. Allele-specific expression of TGFBR1 in colon cancer patients. Carcinogenesis 31:1800-1804, 2010. PMCID: PMC2950937

Townsend AL, Ishler KJ, Shapiro BM, Pitorak EF, Matthews CR. Levels, types, and predictors of family caregiver strain during hospice home care for an older adult. J Soc Work End Life Palliat Care 6:51-72, 2010.

Triozzi PL, Aldrich W, Ponnazhagan S. Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic Toll-like receptor agonists. Vaccine 28:7837-7843, 2010.

Triozzi PL, Aldrich W. Effects of interleukin-1 receptor antagonist and chemotherapy on host-tumor interactions in established melanoma. Anticancer Res 30:345-354, 2010.

Trojan J, Ly A, Wei MX, Bierwagen M, Kopinski P, Pan Y, Ardourel MY, Dufour T, Shevelev A, Trojan LA, Franois JC, Andres C, Popiela T, Chatel M, Kasprzak H, Anthony DD, Duc HT. Antisense anti IGF-I cellular therapy of malignant tumours: immune response in cancer patients. Biomed Pharmacother 64:576-578, 2010.

Truman JP, Garca-Barros M, Kaag M, Hambardzumyan D, Stancevic B, Chan M, Fuks Z, Kolesnick R, Haimovitz-Friedman A. Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery. PLoS One 5:e12310, 2010. PMCID: PMC2924400; Correction PMCID: PMC2947950

Trunzo JA, Poulose BK, McGee MF, Nikfarjam M, Schomisch SJ, Onders RP, Jin J, Chak A, Ponsky JL, Marks JM. The diagnostic efficacy of natural orifice transluminal endoscopic surgery: is there a role in the intensive care unit? Surg Endosc 24:2485-2491, 2010.

Tyagi M, Pearson RJ, Karn J. Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J Virol 84:6425-6437, 2010. PMCID: PMC2903277

Valadkhan S, Jaladat Y. The spliceosomal proteome: at the heart of the largest cellular ribonucleoprotein machine. Proteomics 10:4128-4141, 2010.

Valadkhan S, Nilsen TW. Reprogramming of the non-coding transcriptome during brain development. J Biol 9:5, 2010. PMCID: PMC2871522

Valadkhan S. Role of the snRNAs in spliceosomal active site. RNA Biol 7:345-353, 2010.

Valujskikh A, Baldwin WM 3rd, Fairchild RL. Recent progress and new perspectives in studying T-cell responses to allografts. Am J Transplant 10:1117-1125, 2010.

van Boxel-Dezaire AH, Zula JA, Xu Y, Ransohoff RM, Jacobberger JW, Stark GR. Major differences in the responses of primary human leukocyte subsets to IFN-beta. J Immunol 185:5888-5899, 2010.

Van Grol J, Subauste C, Andrade RM, Fujinaga K, Nelson J, Subauste CS. HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. PLoS One 5:e11733, 2010. PMCID: PMC2908694

Varella L, Rini BI. Emerging drugs for renal cell carcinoma. Expert Opin Emerg Drugs 15:343-353, 2010.

Vassil AD, Murphy ES, Reddy CA, Angermeier KW, Altman A, Chehade N, Ulchaker J, Klein EA, Ciezki JP. Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation therapy or permanent seed implantation. Urology 76:1251-1257, 2010.

Vaziri SA, Kim J, Ganapathi MK, Ganapathi R. Vascular endothelial growth factor polymorphisms: role in response and toxicity of tyrosine kinase inhibitors. Curr Oncol Rep 12:102-108, 2010.

Verheul HM, van Erp K, Homs MY, Yoon GS, van der Groep P, Rogers C, Hansel DE, Netto GJ, Pili R. The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma. Urology 75:608-614, 2010.

Vickers A, Bianco F, Cronin A, Eastham J, Klein E, Kattan M, Scardino P. The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point. J Urol 183:1360-1365, 2010. PMCID: PMC2861336

Vickers AJ, Cronin AM, Roobol MJ, Hugosson J, Jones JS, Kattan MW, Klein E, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Schroder FH, Lilja H. The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group. Clin Cancer Res 16:4374-4381, 2010. PMCID: PMC2937360

Vickers AJ, Fearn P, Scardino PT, Kattan MW. Why can't nomograms be more like Netflix? Urology 75:511-513, 2010. PMCID: PMC2835846

Vickers MM, Choueiri TK, Rogers M, Percy A, Finch D, Zama I, Cheng T, North S, Knox JJ, Kollmannsberger C, McDermott DF, Rini BI, Heng DY. Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy. Urology 76:430-434, 2010.

Viny AD, Clemente MJ, Jasek M, Askar M, Ishwaran H, Nowacki A, Zhang A, Maciejewski JP. MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia. Haematologica 95:1713-1721, 2010. PMCID: PMC2948097

Vogelbaum MA, Leland Rogers C, Linskey MA, Mehta MP. Opportunities for clinical research in meningioma. J Neurooncol 99:417-422, 2010.

von Gruenigen VE, Huang HQ, Gil KM, Gibbons HE, Monk BJ, Rose PG, Armstrong DK, Cella D, Wenzel L. A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study. J Pain Symptom Manage 39:839-846, 2010.

Vricella GJ, Boncher NA, Ponsky LE. Extracorporeal stereotactic radiosurgery for small renal masses. Curr Urol Rep 11:33-37, 2010.

Vricella GJ, Ross JH, Vourganti S, Cherullo EE. Laparoendoscopic single-site nephrectomy: initial clinical experience in children. J Endourol 24:1957-1961, 2010.

Waddell N, Arnold J, Cocciardi S, da Silva L, Marsh A, Riley J, Johnstone CN, Orloff M, Assie G, Eng C, Reid L, Keith P, Yan M, Fox S, Devilee P, Godwin AK, Hogervorst FB, Couch F; kConFab Investigators, Grimmond S, Flanagan JM, Khanna K, Simpson PT, Lakhani SR, Chenevix-Trench G. Subtypes of familial breast tumours revealed by expression and copy number profiling. Breast Cancer Res Treat 123:661-677, 2010.

Waggoner SE, Darcy KM, Tian C, Lanciano R. Smoking behavior in women with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Am J Obstet Gynecol 202:283.e1-283.e7, 2010.

Wahdan-Alaswad RS, Song K, Krebs TL, Shola DT, Gomez JA, Matsuyama S, Danielpour D. Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling. Cancer Res 70:9106-9117, 2010.

Wan Y, Yang M, Kolattukudy S, Stark GR, Lu T. Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor beta2 in cancer cells. J Interferon Cytokine Res 30:677-681, 2010. PMCID: PMC2963631

Wang C, Michener CM, Belinson JL, Vaziri S, Ganapathi R, Sengupta S. Role of the 18:1 lysophosphatidic acid-ovarian cancer immunoreactive antigen domain containing 1 (OCIAD1)-integrin axis in generating late-stage ovarian cancer. Mol Cancer Ther 9:1709-1718, 2010.

Wang H, Karikomi M, Naidu S, Rajmohan R, Caserta E, Chen HZ, Rawahneh M, Moffitt J, Stephens JA, Fernandez SA, Weinstein M, Wang D, Sadee W, La Perle K, Stromberg P, Rosol TJ, Eng C, Ostrowski MC, Leone G. Allele-specific tumor spectrum in pten knockin mice. Proc Natl Acad Sci U S A 107:5142-5147, 2010. PMCID: PMC2841921

Wang H, Molfenter J, Zhu H, Lou H. Promotion of exon 6 inclusion in HuD pre-mRNA by Hu protein family members. Nucleic Acids Res 38:3760-3770, 2010. PMCID: PMC2887941

Wang J, Mao B, Gole JL, Burda C. Visible-light-driven reversible and switchable hydrophobic to hydrophilic nitrogen-doped titania surfaces: correlation with photocatalysis. Nanoscale 2:2257-2261, 2010.

Wang J, Ramakrishnan R, Tang Z, Fan W, Kluge A, Dowlati A, Jones RC, Ma PC. Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays. Clin Chem 56:623-632, 2010.

Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA. Notch promotes radioresistance of glioma stem cells. Stem Cells 28:17-28, 2010. PMCID: PMC2825687

Wang LX, Plautz GE. Tumor-primed, in vitro-activated CD4+ effector T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure. J Immunol 184:5612-5618, 2010. PMCID: PMC2903969

Wang P, Yang Q, Wu X, Yang Y, Shi L, Wang C, Wu G, Xia Y, Yang B, Zhang R, Xu C, Cheng X, Li S, Zhao Y, Fu F, Liao Y, Fang F, Chen Q, Tu X, Wang QK. Functional dominant-negative mutation of sodium channel subunit gene SCN3B associated with atrial fibrillation in a Chinese GeneID population. Biochem Biophys Res Commun 398:98-104, 2010.

Wang WP, Guo C, Berney DM, Ubright TM, Hansel DE, Shen R, Ali T, Epstein JI. Primary carcinoid tumors of the testis: a clinicopathologic study of 29 cases. Am J Surg Pathol 34:519-524, 2010.

Wang X, Elston RC, Zhu X. The meaning of interaction. Hum Hered 70:269-277, 2010.

Wang X, Perry G, Smith MA, Zhu X. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener Dis 7:56-59, 2010. PMCID: PMC2859232

Wang Y, Romigh T, He X, Orloff MS, Silverman RH, Heston WD, Eng C. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Hum Mol Genet 19:4319-4329, 2010. PMCID: PMC2957324

Wang Z, Kyono H, Bezerra HG, Wang H, Gargesha M, Alraies C, Xu C, Schmitt JM, Wilson DL, Costa MA, Rollins AM. Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images. J Biomed Opt 15:061711, 2010.

Warren CB, Lohser S, Wene LC, Pogue BW, Bailin PL, Maytin EV. Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate. J Biomed Opt 15:051607, 2010. PMCID: PMC2955723

Watts KE, Hansel DE. Emerging concepts in micropapillary urothelial carcinoma. Adv Anat Pathol 17:182-186, 2010.

Weaver J, Mahindra AK, Pohlman B, Jin T, Hsi ED. Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification. J Cutan Pathol 37:516-524, 2010.

Weaver J, Rao P, Goldblum JR, Joyce MJ, Turner SL, Lazar AJ, Lpez-Terada D, Tubbs RR, Rubin BP. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma? Mod Pathol 23:1301-1306, 2010.

Weight CJ, Larson BT, Fergany AF, Gao T, Lane BR, Campbell SC, Kaouk JH, Klein EA, Novick AC. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317-1323, 2010.

Weight CJ, Larson BT, Gao T, Campbell SC, Lane BR, Kaouk JH, Gill IS, Klein EA, Fergany AF. Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. Urology 76:631-637, 2010.

Weight CJ, Larson BT, Gao T, Campbell SC, Lane BR, Kaouk JH, Gill IS, Klein EA, Fergany AF. Reply [Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival]. Urology 76:638, 2010.

Weight CJ, Lieser G, Larson BT, Gao T, Lane BR, Campbell SC, Gill IS, Novick AC, Fergany AF. Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol 58:293-298, 2010.

Weinberg R, Fisher DE, Rich J. Dynamic and transient cancer stem cells nurture melanoma. Nat Med 16:758, 2010.

Weinreb I, Goldblum JR, Rubin BP. Factitial soft tissue pseudotumor due to injection of anabolic steroids: a report of 3 cases in 2 patients. Hum Pathol 41:452-455, 2010.

Welford SM, Dorie MJ, Li X, Haase VH, Giaccia AJ. Renal oxygenation suppresses VHL loss-induced senescence that is caused by increased sensitivity to oxidative stress. Mol Cell Biol 30:4595-4603, 2010. PMCID: PMC2950534

Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. Updated response assessment criteria for high-grade gliomas: response assessment in Neuro-Oncology Working Group. J Clin Oncol 28:1963-1972, 2010.

Wendt MK, Smith JA, Schiemann WP. Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 29:6485-6498, 2010.

Wesolowski R, Budd GT. A young woman with a breast mass: what every internist should know. Cleve Clin J Med 77:537-546, 2010.

Wesolowski R, Budd GT. Use of chemotherapy for patients with bone and soft-tissue sarcomas. Cleve Clin J Med 77 Suppl 1:S23-S26, 2010.

Wesolowski R, Cotta CV, Khan G, Pohlman B, Sweetenham J. Successful treatment of Hodgkin lymphoma and acute leukemia. Leuk Lymphoma 51:153-156, 2010.

Wesolowski R, Peereboom D, Weiss P, Elson P, Budd GT. Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC Regimen) in advanced malignancies. Invest New Drugs 28:502-508, 2010.

West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, Podrez EA, Salomon RG, Byzova TV. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467:972-976, 2010. PMCID: PMC2990914

Weyer SM, Werner JJ. Characteristics of nurse practitioners interested in participating in a practice-based research network. J Am Acad Nurse Pract 22:156-161, 2010.

Wiland HO, Pavlidakey PG, Maclennan GT. Nongerm cell malignancies in testicular germ cell tumors. J Urol 183:327-328, 2010.

Williams PS, Carpino F, Zborowski M. Characterization of magnetic nanoparticles using programmed quadrupole magnetic field-flow fractionation. Philos Transact A Math Phys Eng Sci 368:4419-4437, 2010.

Williamson SR, Montironi R, Lopez-Beltran A, Maclennan GT, Davidson DD, Cheng L. Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art. Crit Rev Oncol Hematol 76:112-126, 2010.

Willis D, Canales BK, Cheng L, Maclennan GT. Neural neoplasms of the bladder. J Urol 184:1492-1493, 2010.

Winter JN, Li S, Aurora V, Variakojis D, Nelson B, Krajewska M, Zhang L, Habermann TM, Fisher RI, Macon WR, Chhanabhai M, Felgar RE, Hsi ED, Medeiros LJ, Weick JK, Weller EA, Melnick A, Reed JC, Horning SJ, Gascoyne RD. Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group Correlative Study on E4494. Clin Cancer Res 16:2435-2442, 2010. PMCID: PMC2865202

Wong YN, Hamilton O, Egleston B, Salador K, Murphy C, Meropol NJ. Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices. Oncologist 15:566-576, 2010. PMCID: PMC2892556

Woody NM, Djemil T, Adelstein DJ, Mason DP, Rice TW, Videtic GM. Severe local toxicity after lung stereotactic body radiation therapy: lesional abscess leading to bronchocutaneous fistula requiring surgical marsupialization. J Thorac Oncol 5:1874-1875, 2010.

Wu C, Tang Z, Fan W, Zhu W, Wang C, Somoza E, Owino N, Li R, Ma PC, Wang Y. In vivo positron emission tomography (PET) imaging of mesenchymal-epithelial transition (MET) receptor. J Med Chem 53:139-146, 2010.

Wu C, Wang C, Popescu DC, Zhu W, Somoza EA, Zhu J, Condie AG, Flask CA, Miller RH, Macklin W, Wang Y. A novel PET marker for in vivo quantification of myelination. Bioorg Med Chem 18:8592-8599, 2010.

Wu R, Belinson SE, Du H, Na W, Qu X, Wu R, Liu Y, Wang C, Zhou Y, Zhang L, Belinson JL. Human papillomavirus messenger RNA assay for cervical cancer screening: the shenzhen cervical cancer screening trial I. Int J Gynecol Cancer 20:1411-1414, 2010.

Wu TY, Peng Y, Pelleymounter LL, Moon I, Eckloff BW, Wieben ED, Yee VC, Weinshilboum RM. Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics. Br J Pharmacol 161:1584-1598, 2010.

Wu X, Jeong EK, Emerson L, Hoffman JM, Parker D, Lu ZR. Non-invasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers. Mol Pharm 1:41-48, 2010.

Wu X, Zong Y, Ye Z, Lu ZR. Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats. Pharm Res 27:1390-1397 2010.

Wulan N, Rasool N, Belinson SE, Wang C, Rong X, Zhang W, Zhu Y, Yang B, Tresser NJ, Mohr M, Wu R, Belinson JL. Study of the diagnostic efficacy of real-time optical coherence tomography as an adjunct to unaided visual inspection with acetic acid for the diagnosis of preinvasive and invasive neoplasia of the uterine cervix. Int J Gynecol Cancer 20:422-427, 2010.

Wunderlich T, Cooper G, Divine G, Flocke S, Oja-Tebbe N, Stange K, Lafata JE. Inconsistencies in patient perceptions and observer ratings of shared decision making: the case of colorectal cancer screening. Patient Educ Couns 80:358-363, 2010. PMCID: PMC2971658

Xiao H, Yin W, Khan MA, Gulen MF, Zhou H, Sham HP, Jacobson K, Vallance BA, Li X. Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice. Gastroenterology 139:574-585, 2010.

Xu D, Wang S, Yu WM, Chan G, Araki T, Bunting KD, Neel BG, Qu CK. A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Blood 116:3611-3621, 2010. PMCID: PMC2981480

Xu R, Wang XL, Lu ZR. New amphiphilic carriers forming pH-sensitive nanoparticles for nucleic acid delivery. Langmuir 26:13874-13882, 2010.

Xue LY, Chiu SM, Oleinick NL. Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy. Autophagy 6:248-255, 2010.

Yallapu MM, Foy SP, Jain TK, Labhasetwar V. PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharm Res 27:2283-2295, 2010. PMCID: PMC3001231

Yan Q, Yao D, Wei LL, Huang Y, Myers J, Zhang L, Xin W, Shim J, Man Y, Petryniak B, Gerson S, Lowe JB, Zhou L. O-fucose modulates notch-controlled blood lineage commitment. Am J Pathol 176:2921-2934, 2010. PMCID: PMC2877853

Yang G, Breyer BN, Weiss DA, MacLennan GT. Mucinous tubular and spindle cell carcinoma of the kidney. J Urol 183:738-739, 2010.

Yap TY, Yamokoski AD, Hizlan S, Zyzanski SJ, Angiolillo AL, Rheingold SR, Baker JN, Kodish ED; on behalf of the Phase I Informed Consent (POIC) Research Team. Informed consent for pediatric phase 1 cancer trials: physicians' perspectives. Cancer 116:3244-3250, 2010. PMCID: PMC2892009

Yasmin R, Kannan-Thulasiraman P, Kagechika H, Dawson MI, Noy N. Inhibition of mammary carcinoma cell growth by RXR is mediated by the receptor's oligomeric switch. J Mol Biol 397:1121-1131, 2010. PMCID: PMC2847374

Yavas G, Koyutrk M, Ozsoyoglu M, Gould MP, Laframboise T. Cokgen: a software for the identification of rare copy number variation from SNP microarrays. Pac Symp Biocomput 371-382, 2010.

Yin W, Ye X, Shi L, Wang QK, Jin H, Wang P, Bian Z. TP63 gene mutations in Chinese P63 syndrome patients. J Dent Res 89:813-817, 2010.

Yin XL, Li J. Detecting copy number variations from array CGH data based on a conditional random field model. J Bioinform Comput Biol 8:295-314, 2010.

Yori JL, Johnson E, Zhou G, Jain MK, Keri RA. Kruppel-like factor 4 (KLF4) inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem 285:16854-16863, 2010. PMCID: PMC2878056

Yu JJ, Fu P, Pink JJ, Dawson D, Wasman J, Orem J, Mwanda WO, Zhu H, Liang X, Guo Y, Petros WP, Mitsuyasu RT, Wabinga H, Remick SC. HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma. PLoS One 5:e10477, 2010. PMCID: PMC2871792

Zama IN, Hutson TE, Elson P, Cleary JM, Choueiri TK, Heng DY, Ramaiya N, Michaelson MD, Garcia JA, Knox JJ, Escudier B, Rini BI. Sunitinib rechallenge in metastatic renal cell carcinoma patients. Cancer 116:5400-5406, 2010.

Zentner GE, Hurd EA, Schnetz MP, Handoko L, Wang C, Wang Z, Wei C, Tesar PJ, Hatzoglou M, Martin DM, Scacheri PC. CHD7 functions in the nucleolus as a positive regulator of ribosomal RNA biogenesis. Hum Mol Genet 19(18):3491-501, 2010. PMCID: PMC2928125

Zerikly RK, Amiri L, Faiman C, Gupta M, Singh RJ, Nutter B, Kennedy L, Hatipoglu B, Weil RJ, Hamrahian AH. Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 95:4555-4559, 2010.

Zhang AY, Zyzanski SJ, Siminoff LA. Differential patient-caregiver opinions of treatment and care for advanced lung cancer patients. Soc Sci Med 70:1155-1158, 2010. PMCID: PMC2840198

Zhang K, Sha J, Harter ML. Activation of Cdc6 by MyoD is associated with the expansion of quiescent myogenic satellite cells. J Cell Biol 188:39-48, 2010. PMCID: PMC2812847

Zhang K, Sha J, Harter ML. MyoD, a new function: ensuring "DNA licensing." Cell Cycle 9:1871-1872, 2010.

Zhang X, Motea E, Lee I, Berdis AJ. Replication of a universal nucleobase provides unique insight into the role of entropy during DNA polymerization and pyrophosphorolysis. Biochemistry 49:3009-3023, 2010.

Zhang Z, Kobayashi S, Borczuk AC, Leidner RS, Laframboise T, Levine AD, Halmos B. Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK-signaling in lung cancer cells. Carcinogenesis 31:577-586, 2010. PMCID: PMC2847094

Zhao X, Singh S, Pardoux C, Zhao J, Hsi ED, Abo A, Korver W. Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia. Haematologica 95:71-78, 2010. PMCID: PMC2805740

Zhao Y, Dyck JS, Hernandez BM, Burda C. Enhancing thermoelectric performance of ternary nanocrystals through adjusting carrier concentration. J Am Chem Soc 132:4982-4983, 2010.

Zhao Y, Zhang X, Guda K, Lawrence E, Sun Q, Watanabe T, Iwakura Y, Asano M, Wei L, Yang Z, Zheng W, Dawson D, Willis J, Markowitz SD, Satake M, Wang Z. Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T. Proc Natl Acad Sci U S A 107:2592-2597, 2010. PMCID: PMC2823898

Zheng Q, Zhu J, Shanabrough M, Borok E, Benoit SC, Horvath TL, Clegg DJ, Reizes O. Enhanced anorexigenic signaling in lean obesity resistant syndecan-3 null mice. Neuroscience 171:1032-1040, 2010. PMCID: PMC2991621

Zhou GX, Ireland J, Rayman P, Finke J, Zhou M. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials. Urology 75:257-261, 2010.

Zhou L, Picard D, Ra YS, Li M, Northcott PA, Hu Y, Stearns D, Hawkins C, Taylor MD, Rutka J, Der SD, Huang A. Silencing of thrombospondin-1 is critical for Myc-induced metastatic phenotypes in medulloblastoma. Cancer Res 70:8199-8210, 2010.

Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, Pintilie M, Der S, Seymour L, Jurisica I, Shepherd FA, Tsao MS. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol 28:4417-4424, 2010. PMCID: PMC2988634

Zhu J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 31:4639-4656, 2010. PMCID: PMC2907908

Zhu X, Feng T, Li Y, Lu Q, Elston RC. Detecting rare variants for complex traits using family and unrelated data. Genet Epidemiol 34:171-187, 2010. PMCID: PMC2811752

Zhu X, Tang X, Zhang J, Tochtrop GP, Anderson VE, Sayre LM. Mass spectrometric evidence for the existence of distinct modifications of different proteins by 2(E),4(E)-decadienal. Chem Res Toxicol 23:467-473, 2010. PMCID: PMC2838956

Zhu X. Mitochondrial dysfunction: mitochondrial diseases and pathways with a focus on neurodegeneration. Biochim Biophys Acta 1802:1, 2010.

Ziady AG, Kotlarchyk M, Bryant L, McShane M, Lee Z. Bioluminescent imaging of reporter gene expression in the lungs of wildtype and model mice following the administration of PEG-stabilized DNA nanoparticles. Microsc Res Tech 73:918-928, 2010.

Zou WQ, Langeveld J, Xiao X, Chen S, McGeer PL, Yuan J, Payne MC, Kang HE, McGeehan J, Sy MS, Greenspan NS, Kaplan D, Wang GX, Parchi P, Hoover E, Kneale G, Telling G, Surewicz WK, Kong Q, Guo JP. PrP conformational transitions alter species preference of a PrP-specific antibody. J Biol Chem 285:13874-13884, 2010. PMCID: PMC2859550

Zuba-Surma EK, Klich I, Greco N, Laughlin MJ, Ratajczak J, Ratajczak MZ. Optimization of isolation and further characterization of umbilical cord blood-derived very small embryonic/ epiblast-like stem cells (VSELs). Eur J Haematol 84:34-46, 2010.